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1 - INTRODUCTION 
 
“Prior to the advent of brain the entire cosmic process was “a play before empty benches”; there 
was no color and no sound in the universe, nor was there any flavour or aroma and probably rather 
little sense and no feeling or emotion. Before brains the universe was also free of pain and anxiety.” 
- Roger Wolcott Sperry Evolution of human brain, 1964 
 
Brain is one of the most complex entities. It is constituted mainly of glial cells and neurons, but 
both cell types comprise several sub-populations. There are about fifty different types of neurons 
that take precise contacts, which other neurons generating a tangled network, sustained by glial 
cells. This is the biological basis for the accomplishment of elaborate tasks that regulate animal 
behavior and makes brain the organ of intelligence, consciousness and mind. Indeed 
evolutionally, it guarantees the survival of individuals and of species by solving complex tasks and 
handle dangerous situations, choosing rapidly from the Four F’s instincts (fighting, fleeing, feeding 
and fucking). 
The Triune Brain Theory of Paul D MacLean proposes that during the evolution, the brain 
develops to solve increasingly complex problems, most often associated to the survival and 
adaptation. Hence the most ancient nuclei of the brain control certain behaviors that are 
necessary for the survival, such as exploration, feeding, aggression, dominance and sexuality and 
are therefore conserved among the evolution from reptiles to the human. The aggregate of these 
nuclei was called protoreptilian brain. Subsequently, the paleomammalian brain evolved, where the 
instincts regulated by protoreptilian brain were integrated with the emotions, fear control, 
memory, constituting the limbic system. The latter includes a large number of structures. At the 
end, the newest neomammalian brain allows mammals to consciousness and the higher cognitive 
tasks.  
This theory highlights the importance of midbrain because its nuclei are involved in primitive 
tasks as well as in emotional control. The midbrain functions are mediated mainly by 
dopaminergic neurons that act like a bridge to connect instincts to emotions, although serotonin 
and norepinephrine play an important role in several physiological functions and behaviors, such 
as eating, sleep, circadian rhythmicity, neuroendocrine function and arousal. 
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It must be said that dopamine is not a conventional neurotransmitter that excites or simply 
inhibits the target neurons. Rather, dopamine working through signaling cascades coupled to G-
proteins is capable of modulating the gating of ion channels that orchestrate the response to 
classic neurotransmitters. That is, they change the way neurons respond to the signals from other 
neurons to which are connected synaptically. 
 
1.1 – Mesencephalic dopaminergic neurons 
The catecholamine dopamine (DA) is a neurotransmitter released by an anatomically and 
functionally heterogeneous class of neurons: the dopaminergic neurons.  
In the 1960s the discovery of catecholaminergic nuclei (A) by Carlsson, Falck and Hillarp 
(Carlsson et al. 1962, Falck et al. 1962) allowed us to understand the variety of action mediated 
by this catecholamine. In the mammalian central nervous system (CNS) dopaminergic nuclei 
have a broad distribution and are located in the area A16 of the olfactory bulbs (Gudelsky et al. 
1976), area A17 of the retina (Djamgoz et al. 1992), areas A11-A15 of the diencephalon [e.g. 
hypothalamic arcuate nucleus (A12; Kizer et al. 1976), sub-parafascicular thalamic nucleus (A13; 
Takada 1993)] and areas A8-A10 of the ventral mesencephalon, where is located the largest DA 
population (20000 - 40000 neurons in rodents, 400000 - 60000 in humans; Björklund et al. 
2007; Fig. 1.1). Interestingly, in adult mice their number can vary in response to environmental 
stimuli (Tomas et al. 2015) as the DA neurons in the hypothalamus of adult rats (Dulcis et al. 
2013). 
Figure 1.1:  Midbrain dopaminergic nulcei .  
A) Immunostaining for Tyrosine hydroxilase (TH) on adult mouse ventral midbrain showing 
Substantia nigra (SN; laterally) and ventral tegmental area (VTA; medially); 
B) SN, enlargement. It is possible to distinguish SN pars compacta (SNc), where locate DA 
somata, and SN pars reticulata (SNr) with DA dendrites. 
(di Porzio et al. 1990). 
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The mesencephalic dopaminergic neurons (mesDA) are spread in three nuclei: the retrorubral 
field (RRF, area A8), the substantia nigra (SN, area A9) and the ventral tegmental area (VTA, area 
A10; Fig. 1.2). The retrorubral DA neurons project mainly to SN and VTA and probably 
coordinate the action of these two nuclei (Arts et al. 1996). Others projections of RRF are 
involved in the arousal (Simmons et al. 2011). 
 
 
 
Figure 1.2:  Localization of dopaminergic nuclei  and their  projection in adult  
rodent and human brain. 
A) Dopaminergic neurons are distributed in 10 groups (A8 - A16) from the mesencephalon to 
the olfactory bulb described by Dahlstrom and Fuxe in 1964 (Dahlstroem et al. 1964). A8, A9 and 
A10 nuclei are usually indicated as midbrain dopaminergic neurons. Blu arrows represent nigro-
striatal pathway; green arrows represents meso-cortico-limbic pathway. A8, Retrorubral field; A9, 
Substantia Nigra; A10, Ventral Tegmenta Area. Amyg, amygdala; DA, dopaminergic neurons; GP, 
globus pallidus; Hp, hippocampus; N Acc, nucleus accumbens; OB, olfactory bulb; O. Tub, 
olfactory tubercle; Pit, pituitary; Str, striatum; SVZ, subventricular zone; Thal, thalamus. Images 
from Rodríguez-Traver et al. 2015. 
B) Schematic planar section of adult human midbrain. PAG, periaqueductal gray; ReN, red 
nucleus; OMN, oculomotor nucleus. 
 
A 
B 
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In rodents, DA fibers depart from SN pars compacta (SNc; that contains DA cell bodies while 
the dendritic extensions are located in the pars reticulata where they connect to the intrinsic 
GABAergic neurons) and reach the striatum (corresponding to nuclei caudate-putamen in 
humans) to form the ascending nigrostriatal pathway (NSp). This pathway is involved in the 
extrapyramidal control of motor functions (Kandel et al. 2000) and integrates multiple aspects of 
motor behavior such as: the motivational or decisional aspects, the regulation of movement 
velocity or postural control.   
The extrapyramidal pathway is a complex network constituted by different nuclei: the basal 
ganglia. These ones integrate information from cortex with those of brain stem. Briefly, striatum 
after cortical activation remove the inhibition of internal globus pallidus (GPi) and SNr on the 
thalamus, promoting the feedback signals of thalamus to the cortex. The inactivation of GPi 
and SNr is mediated directly (in the direct pathway) or passing through subthalamic nucleus and 
external globus pallidus (GPe) in the indirect pathway (Fig. 1.3). The dopaminergic neurons of 
SNc act differently on the two pathways: the direct-pathway neurons are facilitated by DA 
activation on DA receptors D1, whereas indirect-pathway neurons are inhibited by activation of 
D2 receptors (Ivanova et al. 2012). Therefore SNc neurons balance the two different pathways 
and are involved not only in the regulation of movement but also in adaptive behavior (Kandel et 
al. 2000). 
Alteration of the nigrostriatal pathway leads to an over-function of inhibitory GABAergic 
circuit from the basal ganglia with subsequent decrease of the thalamic excitation of the prefrontal 
and primary motor cortex.  This determines the progressive loss of muscle control causing the 
pathognomonic symptoms (tremor, rigidity and difficulty to complete simple motor tasks) of 
Parkinson’s disease (PD; Thomas et al. 2007). 
On the other hand, mesDA VTA neurons generate the meso-corticolimbic pathway 
(MCLp), which forms the limbic system projecting to the nucleus accumbens, olfactory tubercle,  
cortical  areas  (prefrontal,  cingulate  and perirhinal  cortex) as  well  as  septum,  amygdala  and  
hippocampus (Fig 1.2A). Thus VTA mesDA neurons regulate superior cognitive abilities such as 
reward, attention and emotions that are the basis of social behaviors (sex, sociality and 
aggression). Dysregulation of MCLp is linked to mood disorders  (Zacharko et al. 1991, Martin-
Soelch 2009), schizophrenia  (Laviolette 2007), attention deficit hyperactivity disorder (ADHD; 
Ohno 2003), drug addiction and hallucinations (Morales et al. 2012).   
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Figure 1.3:  Extrapyramidal system neural  network. It is shown the modulatory action of 
substantia nigra pars compacta (SNc) dopaminergic neurons on the striatum. Excitatory pathways are 
in red; inhibitory pathways are in blue. SNr, Substantia Nigra pars reticulata; GPe, external Globus 
pallidus; GPi, internal Globus pallidus; STN, Subthalamic nucleus; D1 and D2 are different type of 
DA receptor in the striatum (adapted from Kandel et al. 2000). 
 
The two mesDA pathways are not completely separated since their projections partially 
overlap. Indeed a number of studies have shown that the dysfunction of one can alter the 
function of the other (Jellinger 1991, Péron et al. 2012). Moreover DA neurons are also involved 
in the working memory formation by connecting basal ganglia with the prefrontal cortex. This 
specific kind of memory is well described in humans and is necessary to keep “active” in mind the 
acquired information for several seconds, to allow processes like reasoning, comprehension, 
problems resolution, planning and other complex cognitive functions (Lieberman 2009). 
 
1.2 – Dopamine metabolism 
DA was originally considered simply a precursor in the synthesis of noradrenaline and 
adrenaline; only at the end of the fifties Von Euler and Lishajko, and subsequently Bertler and 
Rosengrens, showed that DA is active by itself. Few years later Carlsson, Ehringer and 
Hornykiewicz identified that the loss of DA in the striatum caused PD, proposing the DA 
precursor L-DOPA (L-3,4-dihydroxyphenylalanine) as potential therapeutic drugs (Carlsson 
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1959, Ehringer et al. 1960). Then Carlsson and his collaborators identified in the ventral 
midbrain (Mb) the origins of the DA found in the striatum and in the limbic system (Anden et al. 
1964). 
 
 
Figure 1.4:  Schematic representation of  dopaminergic synapse.  DA, dopamine; TH, 
tyrosine hydroxilase; L-DOPA,  L–3,4–dihydroxyphenylalanine; AADC, Aromatic L-amino acid 
decarboxylase; VMAT2, vesicular monoamine transporter; MAO, monoamine oxidase; COMT, 
catechol-O-methyl transferase; DAT, dopamine active transporter; D2-like dopaminergic inhibitory 
autoreceptors (DRD2); D1-like dopaminergic postsynaptic excitatory receptors (DRD1); AC, 
adenyl cyclase; PNMT, Phenylethanolamine N-methyltransferase; DβH, Dopamine beta-
hydroxylase (adapted from Sharples et al. 2014). 
 
The tyrosine hydroxylase (TH) is the limiting enzyme in the catecholamines biosynthesis; it 
converts tyrosine in the DA precursors L-DOPA (tyrosine itself is derived from phenylalanine by 
phenylalanine hydroxylase, an enzyme related to TH). This reaction takes place mainly in the soma 
and terminals of neurons. TH activity is modulated by its phosphorylation via the protein kinase 
cyclic adenosine monophosphate (cAMP)-dependent (PKA). TH requires tetrahydrobiopterin as 
a cofactor and iron to exert its catalytic activity. In turn, L-DOPA is converted into DA by the 
ubiquitously distributed Aromatic L-amino acid decarboxylase enzyme (AADC; Fig. 1.4). The 
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wide expression of the AADC enzyme makes it possible the therapeutic use of L-DOPA, which 
passes the blood brain barrier, allowing the production of DA in many surrounding cells by 
administration of the DA precursor.  
Following its cytoplasmic synthesis, DA is accumulated in synaptic vesicles through the 
vesicular monoamine transporter (VMAT2), a twelve transmembrane domain protein. VMAT2 
is coupled to the vesicular H+-ATPases (V-ATPases), which functions as ATP-driven proton 
pump keeping the internal milieu in synaptic vesicles acidic, since DA oxidizes rapidly. After the 
activity-induced release, DA can bind to 5 different DA postsynaptic receptors (D1-5). The DRDs 
are G-protein-coupled, 7 transmembrane domain receptors and can be grouped in two families: 
the DRD1 (D1 and D5) and the DRD2 (D2 - D4) that act in an opposite manner, as previously 
mentioned. The DRD1 type triggers an increase in cAMP, while DRD2 determine cAMP 
decrease. In general, both families modulate the cAMP/PKA transduction cascade and the 
intracellular Ca2+ levels. These receptors have selective agonists (Vallone et al. 1999) and specific 
anatomical and cellular distribution that can be pre-synaptic or post-synaptic. The latter types of 
receptors (e.g. D2) are also localized on the DA neurons membranes (autoreceptors), regulating 
DA release as feedback inhibition of DA transmission (Bello et al. 2011). 
To turn-off the DA signals, the DA released in the synaptic cleft is mainly recaptured by the 
dopamine transporter (DAT or SLC6A3) a 12 transmembrane domain Na+/Cl- dependent 
transporter that is target of several drugs (cocaine, amphetamine, etc.) and mice knock-out show 
hyperactivity and insensibility to treatment by these drugs (Amara et al. 1993). 
The DA is also metabolized by catechol-O-methyl transferase (COMT) in homovanillic acid 
(HVA), or degraded to 3,4-dihydroxyphenylacetic acid (DOPAC) by the extracellular or 
mitochondrial monoamine oxidases (MAOs).  
 
1.3 – Development of mesDA neurons 
In the brain, differences among neuron types is far greater than that observed amongst cells in 
any other organ of the body. Each neuronal population develops in a distinct anatomical position 
and establishes specific connections with other cells. This specificity is achieved by a complex 
process that requires orchestrating a great number of factors that define a sort of informational 
grid by an accurate space-time sequence. Developing cells are exposed to a sequential 
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transcriptional activation that follows an accurate genetic program and its interaction with the 
embryonic environment to determine their phenotype.  
The development of mesDA neurons can be broadly divided into 4 stages: early Mb 
patterning; induction and specification of dopaminergic precursors; differentiation of post-
mitotic mesDA neurons; functional maturation of mesDA neurons (Fig. 1.5; Abeliovich and 
Hammond 2007, Perrone-Capano et al. 2008). 
 
 
Figure 1.5:  Schematic model of  mesDA neurons development.  Diagram showing the 
main transcription or inductive factors involved in dopaminergic neurons development, divided in 
phases of the developmental stage in which they are involved (Perrone-Capano et al. 2008). 
 
1.3.1 – Early midbrain patterning: regionalization 
Early in development during the formation of neural tube, the different cell proliferation and 
the different cell responses to inductive factors released from specific zones, called organizers, 
determine the formation of several structures (that became the three brain vesicles forebrain, 
midbrain and hindbrain, which will subsequently divide forming five vesicles, telencephalon, 
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diencephalon, mesencephalon, metencephalon and myelencephalon). In this processes 
transcription factors (TFs) are the promoters of structures development and molecules release. 
For the Mb induction, these factors are mainly growth factors released by the floor plate and the 
mid-hindbrain boundary (MHB or IsO, isthmic organizer) and TFs differently expressed. Otx2 
and Gbx2 are two TFs expressed in a mutually exclusive manner (Hidalgo- Sánchez et al. 1999). 
The former determines the specification and regionalization of telencephalon and mesencephalon 
(Simeone et al. 2002) while Gbx2 is expressed more caudally and it is essential for the correct 
development of hindbrain and cerebellum. Indeed Otx2 null mice fail to generate mesDA that are 
replaced by serotonergic cells (Puelles et al. 2004), probably because Otx2 inhibits the 
homodimeric protein Nkx2.2, a negative regulator for the ventral Mb fate (Prakash et al. 2006). 
Otx2 is also involved in the regulation of some proneural genes like Ascl1  and Neurogenin2 
(Ngn2), involved as well in the proliferation phases of the mesencephalic progenitors (Vernay et 
al. 2005). 
Following the proper formation of the MHB (E8 in mice), other factors are secreted. The 
MHB, that expresses the engrailed transcription factors (En1/2), releases the fibroblast growth 
factor 8 (FGF8) and guides the correct regionalization along the antero-posterior axis of the 
developing CNS (Fig. 1.6). By gene expression analysis and in vitro studies, several other factors 
needed for the correct positioning of the MHB have been identified. Among these the 
transforming growth factor β (TGFβ; Farkas et al. 2003), the LIM-homeodomain factor Lmx1b 
(Smidt, Asbreuk et al. 2000) as well as the morphogenetic factor Wnt1 (Schulte, Bryja et al. 
2005) are involved in these steps. 
Wnt protein family (associated to wingless phenotype in Drosophila) is a class of secreted 
glycoprotein that binds the transmembrane G-protein-coupled receptors frizzled (Fz) determining 
the activation of the cytoplasmic protein dishevelled (Dsh) that regulates transcription of Wnt 
target genes through its intracellular transducer β-catenin. Numerous members of the Wnt/β-
catenin pathway seem to be involved in specification, proliferation and neurogenesis in the 
ventral Mb (Prakash et al. 2006). For instance, null mutations for frizzled3 (Fz3) and frizzled6 
(Fz6) result in a reduction of mesDA neurons (Sousa et al. 2010, Stuebner et al. 2010). 
Importantly, the activation of Wnt pathway is stronger in the hindbrain. 
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Figure 1.6:  Morphogen signaling during neural  tube development.  Schematic 
representation of sagittal (left side) and coronal (right side) views of the midbrain (top) and spinal 
cord (bottom) with the expression pattern for the morphogenes SHH, Wnt1, FGF8 and Retinoic 
Acid (RA) at E9.5.  FP, floor plate; IsO, isthmic organizer; MB, midbrain; NC, notochord; OV, 
otic vesicle; RP, roof plate; MN, Spinal motor neurons; SC, spinal cord; ZLI, zona limitans 
intermedia; r1, rhombomer 1; r2, rhombomer 2; D, dorsal; V, ventral. Image from Allodi et al. 
2014. 
 
 
During the early phases of mouse development (E7.5) Lmx1b is expressed in the MHB 
(Adams et al. 2000, Guo et al. 2007); only at E10.5 it is detectable in the mesDA precursors 
(Smidt et al. 2000). The loss of Lmx1b determines alteration in MHB regulatory genes such as 
Fgf8, Engrailed 1 and 2 (En1/2), Pax2, Gbx2 and Wnt1. So Lmx1b has a role in the formation of 
the MHB and therefore in the development of mesDA neurons (Guo et al. 2007). Indeed specific 
inactivation of Lmx1b in mesDA progenitors and not in the MHB does not alter the 
differentiation of these neurons (Yan et al. 2011). Around E11.5 its expression disappears until at 
E16 when it is expressed in post-mitotic mesDA progenitors and is maintained until the 
adulthood in co-expression with Pitx3 and TH (Dai et al. 2008). Although loss of Lmx1b leads 
to a reduction of mDA neurons (Smidt et al. 2000), in Lmx1b null mice neural precursors express 
Nurr1 (Nuclear Receptor Related 1 protein or Nr4a2) and TH dopaminergic markers but fail to 
express Pitx3. These TH+ neurons lacking Pitx3 expression are lost around birth suggesting a role 
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for Lmx1b in Pitx3 regulation and in mesDA neurons survival. Interestingly, a similar phenotype 
is observed for the Wnt1 null mutant. In this case, the few TH+ neurons generated lack Pitx3 
expression and are lost by E12.5 (Prakash et al. 2006). 
The similar effects caused by loss of these two factors suggest the existence of a regulatory loop 
between Wnt1 and Lmx1b. Lmx1b and Lmx1a seem to be necessary in inducing and/or 
maintaining Wnt1 expression around the MHB (Adams et al. 2000, Guo et al. 2007). Lmx1b 
and Lmx1a together have been shown to regulate proliferation of mesDA progenitors in part 
through the regulation of Wnt1 (Panhuysen et al. 2004). 
 
1.3.2 – Induction and specification of DA precursors 
As yet described, MHB releases FGF8 to determine the antero-posterior axis. In parallel the 
notochord and then the floor plate (FP) release the morphogen sonic hedgehog (SHH) that is 
involved in the determination of dorso-ventral axis. SHH binds patched 1 receptor (Ptc1) 
preventing its inhibition on Smoothened protein (Smo) and triggering the activation of the Gli 
family transcription factors (Gli-1/3; Stone et al. 1996, Taipale et al. 2002). 
The released SHH and FGF8 generate a Cartesian grid in which a gradient of the two 
molecules is established. Cells located at different points in this grid are exposed to specific 
concentrations of morphogens, thus establishing the proper inductive signals for the correct 
differentiation (Hynes et al. 1999). SHH and FGF8 are involved in induction and proliferation 
of mesDA precursors. The ectopic expression of SHH and FGF8 generate mesDA neurons and 
for that reason they are usually used for the in vitro strategies of mesDA differentiation (Lee et al. 
2000). 
Lmx1a, like its homologous Lmx1b, is a LIM homeobox conserved transcription factors. LIM 
TFs have two zinc finger motifs specialized in the interaction with cofactors in order to form 
transcriptional-regulator complexes (Doucet-Beaupré et al. 2015). In mice brain, Lmx1a is firstly 
expressed at embryonic days 8.5 (E8.5) in the dorsal midline (roof plate) of the neural tube and 
then in progenitor zone of ventral midbrain and in otic vesicles (Failli et al. 2002, Millen et al. 
2004, Andersson et al. 2006). Studies on Lmx1a mutant mice dreher show that it is involved in 
many aspect of CNS development such as the formation of roof plate (Millonig et al. 2000), the 
specification of dopaminergic neurons (Andersson et al. 2006) and retina formation in Drosophila 
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(Wang et al. 2015). Its expression is induced by Wnt1/SHH and Foxa1/Foxa2 pathways; the 
former are regulated by Lmx1a generating an autoregulatory loop (Chung et al. 2012). The 
proliferative action of Lmx1a is mediated by Msx1 that in turn positively regulate the expression 
of Ngn2 (Hong et al. 2014) and negatively that of Nkx6.1. Thus Lmx1a mediates the general 
transition from the proliferative zone to the intermediate zone (Andersson et al. 2006, Gale et al. 
2008). 
Lmx1a is co-expressed with Lmx1b in the neural precursor stage and during the post-mitotic 
maturation (Zou et al. 2009). The loss of one can be compensated from the other one as 
confirmed by single KO mice (Ono et al. 2007). Both can ectopically generate mesDA neurons 
(Nakatani et al. 2010) and their structures are homologues at 80%. In a recent work, it has been 
hypothesized that during the specification phase, Lmx1b is required and influences the 
differentiation of several neuronal subtypes in the Mb, including ocular motor and red nucleus 
neurons, while Lmx1a functions seem to be more restricted to the mesDA fate (Deng et al. 
2011). 
FoxA1 and FoxA2 are two additional TFs involved in embryonic development and in tissue 
specification of mesDA by regulating Ngn2 and later Nurr1 and TH (Ferri et al. 2007, Lin et al. 
2009). Interestingly, FoxA2 heterozygous mice show progressive loss of mesDA after birth and 
consequent motor deficits, similarly to the PD associated symptomatology (Kittappa et al. 2007). 
Recent data suggest a role for FoxA2 in the negative regulation of SHH signaling by modulating 
levels and duration, thus further promoting maturation of developing neurons (Metzakopian et 
al. 2012). 
A recently discovered zinc-finger TF, the doublesex and mab-3-related transcription factor 5 
(Dmrt5) has been shown to be crucial in mesDA fate specification (Gennet et al. 2011). This TF 
was identified from a differential expression screening within the ventral Mb cell populations. At 
E10.5 in mouse embryo Dmrt5 expression partially overlaps with Lmx1a and FoxA2 expression 
domain. Since at E12.5 Dmrt5 expression become more restricted to the subventricular zone, 
where TH expression is not detectable, it can be considered a DA neuronal progenitors marker. 
Interestingly, several experiments showed that Dmrt5 over-expression is able to trigger an increase 
in the levels of FoxA2, Lmx1a and Msx1 and a decrease in more laterally expressed markers, 
confirming a role specifically in the mesDA fate induction (Gennet et al. 2011). 
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1.3.3 – Post-mitotic maturation of mesDA neurons 
As shown by 3H-thymidine incorporation studies, the transition of mesDA progenitors from 
the proliferative state to post-mitotic immature neurons takes place, in mice, around E9.5 - E13.5 
as they exit the cell cycle and migrate radially from the ventricular surface (Bayer et al. 1995, 
Abeliovich et al. 2007). In this stage, radially migrating cells start to express TH, an event that 
occurs early (E9.5 in mouse), as suggested by the observation of the first TH+ cells and fibers close 
to the ventricular ependymal layer (di Porzio et al. 1990).   
A network of key transcription factors, such as En1/2, Nurr1, Pitx3 and Lmx1a, is involved in 
the development of post-mitotic mesDA neurons. Here the expression of these factors is restricted 
to the early mesDA neurons, suggesting that the factors function cell-autonomously.  However, 
none of these transcription factors appear sufficient individually to instruct the mesDA 
phenotype, suggesting a network model (Abeliovich et al. 2007). 
The TF Nurr1 together with Nur77 (Nr4a1) and Nor-1 (Nr4a3), constitute the orphan 
receptor subfamily of the steroid nuclear hormone receptors (Zhao et al. 2010). It is considered 
an orphan nuclear receptor in the sense that no ligands have been identified (Mangelsdorf et al. 
1995). The current hypothesis proposes that Nurr1 can regulate transcription in absence of any 
ligand, and other factors can modulate its activity binding to Nurr1 ligand-binding domain 
(Perlmann et al. 2004). This hypothesis has been supported by structural data showing that side 
chains of hydrophobic residues occupy the ligand-binding domain (Wang et al. 2003). Previous 
data also showed Nurr1 capacity to act as a monomer, homodimer or as heterodimer with the 
retinoic acid receptor (RXR; Law et al. 1992, Perlmann et al. 1995) to transactivate target genes. 
Nurr1 gene encodes for a protein of 598 aminoacidic residues identical in human and mouse. Its 
main transactivation domain (AF1, aa. 52-84) is located at its N-terminus, while at carboxylic 
terminal domain (C-ter) there is the putative ligand-binding domain (LBD, aa. 361-598). A 
central DNA binding domain (DBD, aa. 261-335) mediates the binding to specific NGF-
responsive elements (NBRE; Castro et al. 1999, Alvarez-Castelano et al. 2013, Volakakis et al 
2006, Flaig et al. 2005, Wang et al. 2003).	   
Phosphorylation and sumoylation are proposed as regulatory events of Nurr1 activation 
(Jacobsen et al. 2008, Sacchetti et al. 2006, Arredondo et al. 2013), but also sub-cellular 
localization of the TF influences its activity (Kadkhodaei et al. 2013). Its sub-cellular localization 
is regulated by two nuclear localization signals (NLS1/2, aa. 287-314 and 338-350) and two 
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nuclear exporting signals (NES1/2, aa. 443-452 and 568-577), located in its structure (García-
Yagüe et al. 2013).	  
Nurr1 is predominantly expressed in the SN, VTA, limbic system and olfactory bulbs 
(Zetterström et al. 1997). In mouse its expression starts at E10.5, one day before TH appearance 
(Volpicelli et al. 2004, Jankovic et al. 2005), and persists in the adult brain. The highest increase 
in Nurr1 levels is observable between E13 and E15 in rat, a crucial phase for mesDA maturation 
and for the organization of SN and VTA (Volpicelli et al. 2004). Null mice for Nurr1 show 
agenesis of TH+ cells in the Mb, as proven by the absence of several DA markers and consequent 
loss of striatal innervations (Zetterström et al. 1997). These mutant mice are born with a normal 
frequency but they die within two days and they show a complete loss of mesDA, both in the SN 
and in the VTA, but not in the other CNS DA nuclei. The over-expression of Nurr1 in different 
cell types induces the DA phenotype (Wagner et al. 1999, Chung et al. 2002). Nurr1 has been 
found decreased in PD patients and mutations in its gene are associated to rare form of familiar 
PD (Le et al. 2003, Sleiman et al. 2009, Decressac et al. 2013).	  
Nurr1 regulates the expression of several DA markers, such as TH (Zhou et al. 1995), Dat 
(Giros et al. 1996), Vmat2 (Colebrooke et al. 2006), p57Kip2 (Joseph et al. 2003) and c-Ret (Jain et 
al. 2006, Kramer et al. 2007). Nurr1 has also a role in the maintenance of DA population by 
regulating the expression of Bdnf (Volpicelli et al. 2007). However many other genes involved in 
the normal mesDA differentiation are normally expressed during the early phases of embryonic 
development in Nurr1 null mice. Most likely, the explanation could be that more than one 
regulatory pathway act for the realization of the correct phenotypic maturation of mesDA 
(Saucedo-Cardenas et al. 1998, Wallén et al. 1999, Smidt et al. 2004). 
During embryonic development Pitx3 (Pituitary homeobox 3, since the first member of this 
family was found to be necessary in the pituitary gland development) is expressed in several 
tissues but after birth it is detectable only in mesDA where it is present also during adulthood 
(Smidt et al. 1997). Aphakia mutant mice (ak), harbouring a spontaneous mutation in the gene 
coding for Pitx3, have motor impairment due to specific loss of mesDA neurons in SN while 
VTA appears unaffected (Smidt et al. 2007). Pitx3 expression in SN precedes that of TH while in 
VTA it occurs simultaneously (Maxwell et al. 2005). These data strongly suggest that specific 
differentiation programs must take place in the two DA subpopulations, thus explaining their 
different susceptibility to the loss of Pitx3. 
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Targets of Pitx3 are the aldehyde dehydrogenase Ahd2, involved in the retinoic acid (RA) 
synthesis (Jacobs et al. 2007), Vmat2 and Dat (Hwang et al. 2009). As yet described also Nurr1 
regulates these genes and both the TFs bind the co-repressor PSF (splicing factor PTB-associated; 
Jacobs et al. 2009). These evidences suggest a relationship between the two TF (Jacobs et al. 
2009). Indeed, in a recent work conducted in our laboratory, we demonstrated that Nurr1 
directly binds and activates a non-canonical NBRE element on the Pitx3 promoter (Volpicelli et 
al. 2012). 
The yet described Lmx1a has recently been correlated also to the maturation of mesDA 
neurons, since it regulates Dat, Vmat2 and Pitx3 (Chung et al. 2012). This hypothesis is 
supported also by the maintained expression of this TF in post-mitotic cells TH+/Nurr1+ 
(Andersson et al. 2006). Lmx1a inhibits non-dopaminergic destinies (Deng et al. 2011) and 
regulates axonal guidance promoting Slit2 expression (Yan et al. 2011). 
Like Lmx1a, also Lmx1b is involved in the maturation of post-mitotic cells by regulation of 
Pitx3.  At the same time, Lmx1b KO mice show specific loss of mature mesDA neurons. 
(Simeone 2005) 
TFs En1 and En2, like Lmx1b, are important during the first phase of MHB formation (Liu et 
al. 2001) but their expression is not detectable anymore till E11.5 when En1 and En2 start to be 
expressed again in ventral mesDA differentiating neurons. This expression is maintained into and 
throughout the adulthood (Simon et al. 2001, Albéri et al. 2004). En1 and En2 are required to 
prevent apoptosis suggesting a role in maintenance and survival of ventral mesDA (Albéri et al. 
2004). 
 
1.3.4 – Functional maturation and survival of dopaminergic neurons 
The functional maturation of mesDA neurons starts after they reach of the striatum. In mouse 
the Dat gene is expressed only at E15.5 after the connection to striatum (Fiszman et al. 1991). 
Furthermore in vitro maturation of mesDA neurons is enhanced co-culturing striatal cells 
(Prochiant et al. 1979, di Porzio et al 1980, Perrone-Capano et al. 2000). 
Numerous molecules mediate the guidance of neural projection to their targets. EphrinB2, 
involved in axonal guidance, and its receptor EphB1 have been shown to facilitate the SN DA 
striatal innervation, where the EphB1 is expressed by mesDA neurons, mainly in SN, and 
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EphrinB2 is expressed in the striatum (Yue et al. 1999). Furthermore EphrinB2, added in 
mesencephalic primary cultures, results in an upregulation of Nurr1 transcript (Calò et al. 2005). 
Also semaphorins and netrin signals have been associated in the formation of mesDA circuits 
(Torre et al. 2010, Xu et al. 2010). 
Other factors are	  Slit-2 and its receptor Robo. Slit-2 seems to be regulated by Lmx1a (Smidt at 
al. 2007) and acts as chemorepellant for mesDA projections inhibiting in vitro their axonal 
growth (Lin et al. 2005, Dugan et al. 2011).	  	  
After the reaching of their target, mature neurons receive trophic signals released from post-
synaptic cells. This process ensures that unnecessary or non-functional neurons dye. During post-
natal development there are two moments, around post-natal day 2 (P2) and around P14, when 
mesDA neurons undergo towards naturally-occurring cell-death (Burke 2003). During these 
phases functional neurons receive numerous surviving factors like the glial cell line-derived 
neurotrophic factor (GDNF; Lin et al. 1993, Beck et al. 1995, Akerud et al. 1999), the brain-
derived neurotrophic factor (BDNF; Hyman et al. 1991), and the more recently identified 
dopamine neurotrophic factor (CDNF; Krieglstein 2004, Lindholm et al. 2007). Both GDNF 
and BDNF show a protective role on mesDA neurons, following a number of experimental 
lesions. They also promote neuronal survival and differentiation in vitro (Hyman et al. 1991, 
Feng et al. 1999, Consales et al. 2007). 
The absence of neurotrophic signals can be the molecular basis of neurodegeneration and, from 
the other hand these molecules could be therapeutic drugs for treatment of DA-associated 
neurological diseases. 
 
1.4 – In vitro generation of mesDA neurons 
In vitro generation of mesDA neurons is an essential step in research since it could unveil 
mechanisms associated to the physio/pathological conditions of nigrostriatal and meso-cortico-
limbic pathways. To this purpose novel knowledge on the molecular mechanisms underlying 
mesDA development as well as advances in stem cell biology could allow to generate unlimited 
numbers of DA cells and overcome the technical limitations nowadays still related to neurons 
transplants in PD patients. 
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Stem cells are the “carte blanche” on which every cell phenotype can be drawn. These are 
undifferentiated or not fully differentiated cells and therefore able to self-renew and to give rise to 
one or more specific cell type. Based on their capacity in differentiating in all or just few cell types 
there are more stem cell types. The most powerful are the embryonic stem cells (ESC), due to the 
lowest differentiating rate that allow generating roughly every cell type. In contrast multipotent 
and pluripotent stem cell lines can generate less cell types, but can be derived also from adult 
tissues, as the adipose-derived adult stem cells (ADAS; Gimble et al. 2003) and for these reasons 
can be useful to generate cell phenotypes from disease affected patients.	   
From the brain it is possible to isolate neural stem cells (NSC) that are stem cells able to give 
rise to every glial and neuronal subtype. NSCs were obtained the first time in 1992 for in vitro 
cultures (Reynolds et al. 1992) and later in 1997 they proved to be a good tool for neural 
developmental studies (McKay 1997). 
Several studies have shown that ESC and NSC cultures can generate TH+ cells expressing 
mesDA phenotypic markers and that the in vitro developmental program appears to recapitulate 
the temporal course of normal mesDA development (Kim et al. 2002, Barberi et al. 2003, 
Martinat et al. 2004, Sonntag et al. 2004, Andersson et al. 2006). To direct the lineage-specific 
neuronal differentiation, including the mesDA phenotype, instructive factors are required. 
Soluble factors implicated in the specification of mesDA in vivo (morphogens, trophic and 
growth factors) have been proved to enhance the differentiation and survival of the DA 
phenotype in vitro (Krieglstein 2004, Volpicelli et al. 2004). In 2003 Ying and Smith showed 
that the addition of SHH and FGF8 to the medium was sufficient to strongly increase the 
number of TH+ neurons obtained in vitro (Ying et al. 2003). 
Over-expression of cell-intrinsic transcription factors such as Nurr1 (Chung et al. 2002, Kim et 
al. 2002, Sonntag et al. 2004) and Pitx3 (Chung et al. 2005) resulted to be another useful 
approach to drive mesDA phenotype. Over-expression of Lmx1a in ESC also promotes mesDA 
differentiation, but only in the presence of SHH (Andersson et al. 2006). 
The induced pluripotent stem cells (iPSC) are derived from de-differentiation of yet 
committed cells by over-expression of specific transcription factors (Takahashi et al. 2006) thus to 
potentially derive patient-specific stem cells to differentiate in the damned phenotype. DA 
neurons have been also obtained from PD patients’ derived-hiPSC as a suitable in vitro model for 
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the pathology (Soldner et al. 2009). Upon transplantation, iPSC-derived DA neurons were able 
to improve the altered motor behavior in a rat model of Parkinson's disease (Wernig et al. 2008).  
Another milestone in cell reprogramming studies was achieved by trans-differentiating adult 
somatic cells directly to other defined cell types. Vierbuchen and colleagues have been able to 
directly convert post-natal fibroblasts into functional neurons in vitro, called induced neuronal 
cells (iN), over-expressing by viral infections a combination of only three factors, Ascl1, Brn2 and 
Myt1l (Vierbuchen et al. 2010). Subsequently, functional mesDA, called induced dopaminergic 
cells (iDA) have been obtained in vitro over-expressing a minimal set of TFs in mouse and human 
PD patient-derived adult fibroblast: Ascl1, Nurr1 and Lmx1a (Caiazzo et al. 2011), Ascl1, Brn2, 
Mytl1, Lmx1a and FoxA1 (Pfisterer et al. 2011), Ascl1, Ngn2, Sox2, Nurr1 and Pitx3 (Liu et al. 
2012) or in mouse cortical astrocytes using Ascl1, Nurr1 and Lmx1b (Addis et al. 2011).  
It is particularly significant in the context of this thesis the possibility to obtain iN from human 
fibroblast also by over-expressing microRNAs (miRNAs) and not TFs, and recent data confirm 
this potential direction (Ambasudhan et al. 2011, Yoo et al. 2011, Xue et al. 2013).  
miRNAs are a class of evolutionary conserved small non-coding single-strand RNAs 
(~22nucleotides) processed from pri-pre-miRNA precursors in nucleus and cytosol (Lee at al. 
2003, Grishok et al. 2001). They are involved in embryonic development, cell differentiation and 
many others biological processes (He at al. 2004). miRNAs act as post-transcriptional regulators 
of gene expression, by targeting partially complementary sequences in the 3' untranslated regions 
(UTRs) of the target messenger RNA (mRNAs) that are in turn directed to degradation or 
translational repressed (Bartel et al. 2004). Some works shows DA impairment after alteration of 
DA-specific miRNA processing deprivation (Kim et al. 2007, Huang et al. 2010). Regarding 
more specifically the dopaminergic neurons, nowadays very few miRNAs have been identified as 
involved in their development or function. miR-133b is enriched in human Mb, where it is 
thought to regulate the maturation and function of mesDA through a negative feedback circuit 
involving the transcription factor Pitx3 (Kim et al. 2007). miR-218 has been found to be 
expressed in the ventral midbrain of E12.5 mouse embryos, and specifically lost in the Wnt1-Cre 
conditional knock out (Huang et al. 2010). miR-132 is expressed in ESC-derived TH+ cells and 
regulates Nurr1 mRNA (Yang et al. 2012). Studies on miRNA expression in neuronal diseases 
suggest a role of these molecules in neurodegeneration (Kim et al. 2007, Hébert et al. 2008, 
Doxakis et al. 2010). 
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The increasing knowledge about the role played by miRNAs in the pathogenesis of this kind of 
diseases will provide important insights into molecular mechanisms of the disease, and could 
eventually generate novel targets for therapeutic intervention. 
 
1.5 - Aim of the present work 
The research project of this PhD thesis is focused on the study of molecular mechanisms 
involved in the acquisition and maturation of midbrain dopaminergic neurons and on the study 
of transcription factors essential for mesDA differentiation. 
As previously described, in the mammalian brain the circuits formed by DA neurons are the 
nigrostriatal and meso-cortico-limbic pathways. These pathways are essential for homeostasis, 
motor control, reward mechanisms and modulation of affective and emotional states. 
Dysfunctions of these circuits are involved in serious neurological and psychiatric diseases 
(Parkinson’s disease, schizophrenia, ADHD, DOPA-responsive dystonia, etc.). The mesDA 
neurons are relatively few, therefore it is useful to generate in vitro model systems enriched in DA 
neurons to dissect the molecular events involved in mesDA differentiation and to possibly use 
these mesDA neurons in disease animal models and in regenerative medicine.  
Thus, the first aim of my PhD thesis was to generate in vitro a large amount of DA neurons 
from different cell types and dissect the overlapping and distinct roles of the transcription factors 
Nurr1 and Lmx1a. As described in the Introduction, Nurr1 is an orphan nuclear receptor with 
no known ligands. It is involved in the mesDA specification by direct regulation of many DA 
genes (such as Th, Vmat2 and Dat) and its loss determines agenesis of mesDA neurons 
(Zetterström et al. 1997, Saucedo-Cardenas et al. 1998). Lmx1a has been recently described as 
positive regulator of Th, Vmat2 and Dat (Chung et al. 2012). Considering the importance and 
the role of these two transcription factors in vivo, my first step was to analyze whether Nurr1 and 
Lmx1a could have a role during in vitro DA differentiation and consequently to set-up a new 
protocol for mesDA differentiation useful to apply on different cell lines.  
After the generation of this in vitro model enriched in DA neurons, the second step was to 
verify if it could exist a possible interaction between Nurr1 and Lmx1a during mesDA 
differentiation and maturation. 
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As afore mentioned, in the last few years several experimental results have shown the 
importance of miRNAs in brain development and function. miRNAs dysregulation has also been 
suggested to be involved in specific dopaminergic (DA) neurons-affecting pathologies, such as 
Parkinson’s disease (PD) or schizophrenia. However miRNAs exclusively related to DA neurons 
development and function, have not yet been identified. Thus, the second aim of my PhD thesis 
was to identify miRNAs involved in DA development and differentiation and if there was a 
synergy between miRNAs and the transcription factors Nurr1 and Lmx1a to promote DA 
differentiation. 
This work contributes to add new and interesting information on the molecular mechanisms 
underlying the mesDA differentiation and maintenance, leading to the identification of new 
molecular targets for potential therapeutic strategies to cure pathological disorders affecting the 
DA system. 
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2 - MATERIALS AND METHODS 
 
2.1 – Lentiviral production 
Last generation lentiviruses have been constructed in order to contain less than 10% of the 
original viral genome. They express only the sequences needed for reverse transcription and 
integration of the gene expression cassette into the host genome. To further increase the security 
level, these genes are cloned in three different vectors to minimize the risk of recombination 
event. To further minimize the possibility to generate functional autoreplicant viruses, the Psi (ψ) 
sequence, responsible for the viral genome packaging, is localized exclusively on the exogenous 
gene-containing transfer vector. The gene expression is under a control of a doxycycline inducible 
promoter (Tet-ON). The used vectors for the lentiviral particles production were: a Gag/Pol 
containing pMDL vector, a pRev vector, a pVSV-G vector and the exogenous gene-containing 
transfer vector Tet-O-FUW. Moreover, a prtTA vector, expressing the reverse tetracycline 
transactivator (rtTA) protein, in combination with pMDL, pRev and pVSV-G was necessary to 
induce gene expression in the presence of the antibiotic tetracycline or one of its derivatives (e.g. 
doxycycline; rtTA vector was supplied by Dr. Caiazzo, IGB, Naples). For all these vectors 
Gigapreps were made using the EndoFree Plasmid Gigaprep (Qiagen) following the manufacturer 
instructions.  
 
2.1.1 – Cloning exogenous gene vectors 
The genes to over-express are cloned into Tet-O-FUW transfer vector. Briefly genomic DNA 
from E14 embryonic mesencephalon was used as template. Oligos were designed in a way to 
amplify specific gene containing specific restriction sites (Tab. 2.1). Amplicons were directly, 
without the restriction passage, cloned into a pCR®2.1-TOPO® TA (Invitrogen) vector following 
the TOPO® TA Cloning Kit (Invitrogen) subcloning protocol. In order to isolate the insert on 
each gene-containing TOPO TA plasmid was restricted with a specific enzyme (4 h at 37°C). 
Insert band was extracted from the agarose using the PureLink® Quick Gel Extraction Kit 
(Invitrogen) according to the provided instructions. To clone it directly or indirectly in Tet-O-
FUW (or Tet-O-FUW_IRES-Cherry or Tet-O-FUW_IRES-GFP) was linearized with EcoRI. 
The addition of specific tags to Nurr1 (or its truncated forms previously obtained in our 
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laboratory) and Lmx1a is achieved by subcloning them respectively into pCMV10-3xFlag and 
pcDNA3.1-V5HIS. 
For the ligation step, 50 ng of vector were used. The amount of insert to use for the ligation 
reaction was calculated using following formula:  
 
!"  !"#$%& = !"  !"#$%&×!"#  !"#$%&!"#  !"#$%& ×3 
 
A control reaction was performed without adding the insert to the reaction. The enzyme I used 
was a T4 ligase (NEB) and the reaction buffer was the one provided by the company. Ligation 
was conducted over-night at 16°C in a final volume of 10 µl with 400 units enzyme. 5 µl of this 
reaction were used to transform 50 µl of competent DH5α cells (Invitrogen) following the 
standard transformation protocol: 30' (minutes) on ice, heat shock at 42°C for 30'' (seconds), 2' 
on ice, cells suspension in 250 µl SOC medium (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 
2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose), followed by 1 h growth in 
agitation at 37°C. Finally the cells were seeded on Lysogeny broth (LB)-Agar plates (10 g NaCl, 
10 g Bacto-tryptone, 5 g yeast extract, 20 g Bacto-agar) containing ampicillin (50 ng/ml) and 
growth over-night at 37°C. Single colonies were screened by PCR. Positive colonies were growth 
in 5 mL LB (10 g NaCl, 10 g Bacto-tryptone, 5 g yeast extract) containing ampicillin (50 ng/ml). 
Plasmidic DNA was isolated using the PureLink Quick Plasmid Miniprep (Invitrogen) and later 
sequenced. 
 
2.1.2 – Transfection and lentiviral production 
For the viral particles production (Tiscornia et al. 2006), 8.2 millions HEK293T cells were 
plated in 150 mm × 25 mm dishes in DMEM (Invitrogen) supplied with 10% FBS (Euroclone), 
25 mM Hepes (Invitrogen), 100 U/mL Streptomycin and 100 µg/mL Penicillin (Pen/Strep, 
Sigma-Alrdich). 24 h later an 80% confluence is generally obtained. Medium was replaced by 
IMDM medium (Invitrogen), 10% FBS, Pen/Strep. 3 h later the 4 vectors was co-transfected 
following the calcium phosphate transfection protocol.  
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Amplif ied cDNA Oligo sequences with restr ict ion sites Cloning Enzyme 
3xFlagNurr1 Fw GCGCCAATTGATGGACTACAAAGACCATGA MfeI 
 Rv GCGCCAATTGTTAGAAAGGTAAGGTGTC MfeI 
3xFlagΔCter-Nurr1 Fw GCGCCAATTGATGGACTACAAAGACCATGA MfeI 
 Rv CGCGCAATTGTTACGGCTTCGAGGGT MfeI 
3xFlagΔNter-Nurr1 Fw GCGCCAATTGATGGACTACAAAGACCATGA MfeI 
 Rv GCGCCAATTGTTAGAAAGGTAAGGTGTC MfeI 
Lmx1aV5-HIS Fw GCGCCAATTGGCTTGAACATGTTGCACGG MfeI 
 Rv GCGCCAATTGTGATCAGCGGGTTTAAACTCA MfeI 
mmu-miR-27a-3p (687 bps) Fw CCGAATTCGTGTTCAGCTATGTGAGACC EcoRI 
 Rv CCGAATTCCCCATCTATCTGCTTTGGG EcoRI 
mmu-miR-29a-3p (336 bps) Fw CCGAATTCTAAGCCTTCTCTGGAAGTGG EcoRI 
 Rv CCGAATTCTTAACCATGCTGTTGCTGG EcoRI 
mmu-miR-34b/c-5p (983 bps) Fw CCGAATTCGGCTTGCGGGAAGAAGGAC EcoRI 
 Rv CCGAATTCTAGCAGCTAAGGGCTAGCGG EcoRI 
mmu-miR-132-3p (562 bps) Fw CCGAATTCGCTGGGACATCTTTGACG EcoRI 
 Rv CCGAATTCCTCTTGCTCTGTATCTGCC EcoRI 
mmu-miR-148a-3p (294 bps) Fw CCGAATTCTCTTCTTTGCCTTCACTGG EcoRI 
 Rv CCGAATTCTCAGGTTCTTCACAAAGCC EcoRI 
mmu-miR-204-5p (309 bps) Fw CCGAATTCCCGGAGAATCAAGATGAGC EcoRI 
 Rv CCGAATTCGTTATGGGCTCAATGATGG EcoRI 
mmu-miR-210-3p (306 bps) Fw CCGAATTCAGGGGGATATGGGTATTGG EcoRI 
 Rv CCGAATTCCACCCTGTCTATCTGAATCC EcoRI 
mmu-miR-218-1-5p (374 bps) Fw CCGAATTCGATCATACACAATCTGCGGGAAG EcoRI 
 Rv CCGAATTCGGACATTTGTTATTCTCCCCTC EcoRI 
mmu-miR-219-1-5p (358 bps) Fw CCGAATTCCATTCACTCGTGTGCTCC EcoRI 
 Rv CCGAATTCCCCAACTTCTCTCAAGCC EcoRI 
mmu-miR-370-3p (313 bps) Fw CCGAATTCGTGGGTGTGGCTTTGAGG EcoRI 
 Rv CCGAATTCCCCTTTCACAAATCTTTGCCC EcoRI 
mmu-miR-375-3p (346 bps) Fw CCGAATTCCGCCACTGCCGCCGACGTG EcoRI 
 Rv CCGAATTCGGCGGGGCCTGATGGGAACC EcoRI 
mmu-miR-494-3p (322 bps) Fw CCGAATTCGTCTCAGGCAATTCTGTGG EcoRI 
 Rv CCGAATTCATGCCATACTCCCATGTCC EcoRI 
Table 2.1:  Oligos for lentivira l  construction. 
 
In details, for each dish, a solution was prepared containing 270 mM CaCl2, 6.25 µg pRev, 9 
µg pVSVG, 14.6 µg pMDL and 32 µg of insert containing transfer vector. After 5' of incubation 
at room temperature, drop-by-drop, in low agitation, a 2xHBS pH 7.12 (NaCl 280 mM, 
Na2HPO4 1.5 mM, HEPES 50 mM) solution was added to the vectors mix and incubated for 
15' at room temperature. Later, the entire solution was spread, drop by drop, in culture medium 
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and HEK293T cells were incubated at 37°C and 5% CO2. 12 h later, medium was refreshed and 
reduced its amount. 30 h later, medium was harvested, filtered (0.22 µm filters) and ultra-
centrifuged at 19400 rpm at 20°C for 2 h (Optima L90K; Beckman Coulter). Lentiviruses 
containing pellet was resuspended in PBS and stored at -80°C. 
Lentiviruses infectivity and the ‘maximum tolerated dose’ were empirically determined through 
subsequential infections on HEK293T cells with increasing amounts of virus. 
In my experiments, infections were performed just adding both Tet-O-FUW-Insert viruses and 
rtTA viruses to culture medium. At the same time or later doxycycline (4 µg/ml) was also 
supplied to the medium. 
 
2.2 - Cell  cultures 
Materials for tissue culture, like multiwell plates, serological pipettes or pipette tips, were 
purchased from Corning, BD Biosciences or Nunc. All steps were carried out inside a laminar 
flow sterile hood (Jupiter) to avoid contamination. All the equipment was sprayed with Ethanol 
(70%) before use. Cells were incubated at 37°C with 5% CO2 in a humidified incubator 
(Thermo Forma). Dissections were performed with horizontal flow hood (Hermes II). All the 
factors and reagents mentioned in the below described methods are listed in Table 2.2. 
 
2.2.1 - HEK293T 
Human embryonic kidney 293T (HEK293T) cells were generated from human embryonic 
kidney cells obtained from a single apparently healthy foetus legally aborted. In the early 70s, 
these cells were genetically transformed with Adenovirus 5 DNA to obtain a stable cell line 
(Graham et al. 1977). 
Cells were maintained at 37°C with 5% CO2 in a humidified incubator, in DMEM with 10% 
foetal bovine serum (FBS), Pen/Strep and 25 mM Hepes.  
 
2.2.2 - Animals and dissections 
Timed pregnant wild type C57BL/6 (Charles-River) or C57BL-6-Tg.pTH-GFP (Dr. 
Hideyuki Okano) mice were sacrificed in accordance with Society for Neuroscience guidelines 
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and Italian law. The embryonic age (E) was determined by considering the day of insemination 
(as confirmed by vaginal plug) as day E0. Embryos from day 12.5 (El2.5) or E14.5 of gestation 
were quickly removed and placed in phosphate buffered saline (PBS), without calcium and 
magnesium, and supplemented with 33 mM glucose. The ventral midbrain was carefully 
dissected under a stereoscope in sterile conditions and processed for cell cultures. Tissues were 
pooled and triturated with a mechanical dissociation. 
 
Description Manufacturer Catalogue number 
Fibronectin Millipore FC010 
Gelatine Sigma-Aldrich G1393 
Laminin Sigma-Aldrich L2020 
Poly-D-lysine Sigma-Aldrich P7405 
DMEM Invitrogen 11995065 
DMEM/F12 Invitrogen 21331-020 
F12 Invitrogen 21700-026 
GMEM Sigma-Aldrich G5154 
IMDM Invitrogen 31980-030 
MEM Invitrogen 61100-087 
Neurobasal NBM Invitrogen 21103-049 
FBS Euroclone ECS0180L 
FCS Biosera 1810-500 
B27 Invitrogen 17504-044 
B27 wo vit. A Invitrogen 12587-010 
N2 Invitrogen 17502-048 
βmercaptoethanol Invitrogen 31350-010 
HEPES Invitrogen 15630-106 
L-glutamine Euroclone ECB3000D 
Na-piruvate Invitrogen 11360-039 
NEAA Invitrogen 11140-035 
Pen/Strep Sigma-Aldrich P0781 
Trypsin Sigma-Aldrich T4799 
DNase Sigma-Aldrich DN25 
Activin R&D 338-AC-025 
bFGF Sigma-Aldrich F0291 
EGF Sigma-Aldrich E9644 
cAMP analog Sigma-Aldrich D0627 
Doxycycline Clontech 631311 
FGF8 Sigma-Aldrich F6926 
L-ascorbic acid Sigma-Aldrich A4544 
LIF Millipre ESG1107 
SHH R&D 1845-SH-100 
SAG Sigma-Aldrich SML1314 
Table 2.2:  Factors  and reagents used for cel l  cultures.  
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2.2.3 - Mesencephalic primary cultures (mE12.5-PCs) 
Single cells were obtained from embryonic midbrain as previously described (Prochiantz et al. 
1979, di Porzio et al. 1980). Briefly, the tissues were transferred into a 15 mL tube and 
mechanically dissociated with a sterile pipette in a solution containing 0,01% pancreatic DNAse. 
The cell suspension was centrifuged 5' at 100 g and resuspended in plating medium and counted. 
For the viable count, cell suspension was diluted 1:10 with 0,1% Trypan blue and loaded into a 
Burker’s counting chamber slide. Cell concentration was determined on the basis of the total cell 
count, the dilution factor and the trypan blue exclusion.  
Dissociated cell were plated at a density of 4 × 104 cells/cm2 on multiwells previously coated 
with 15 μg/mL poly-D-lysine for 1 h at 37°C and washed three times with sterile H2O. Cells 
were grown in NBM, supplemented with B27, 0.5 mM L-glutamine, Pen/Strep, bFGF (20 
ng/mL) FGF8 (10 ng/mL) and SHH (50 ng/mL) to induce mesDA phenotype.  
After 3 days in culture (days in vitro, DIV) half of the medium was replaced and inducible 
lentiviruses were added at respective dilutions. At DIV6, proliferative medium was replaced with 
a differentiating medium, NBM supplemented with B27, 100 mM L-glutamine, Pen/Strep, 
Ascorbic acid (200 μM), and 1 mM dibutyryl cyclic adenosine 3’, 5’-monophosphate (cAMP). 
From DIV6 the expression of transgenes was induced by the addition of doxycycline (4μg/mL) to 
the medium. At DIV12 cells were fixed or collected for further analyses. 
 
2.2.4 - mes-c-myc-A1 
mes-c-myc-A1 (A1) cells were obtained from embryonic mesencephalon at day 11 and 
immortalized by the c-myc proto-oncogene (Colucci-D'Amato et al. 1999). A1 are cultured in 
minimal essential medium MEM/F12 (Invitrogen) supplemented with 10% FBS and Pen/Strep. 
Before seeding the cells, plates were previously coated with 15 µg/mL poly-D-Lysine for 1 h at 
37°C and washed three times with sterile water. 
For lentiviruses infections and mesDA differentiation, cells were plated at 1 × 104 cells/cm2 
density and infected 24 h later. At the same time, expression of the inserted TF was induced 
adding doxycycline (4 µg/mL) to the medium. 48 h later the infection, medium containing serum 
was replaced by MEM/F12 supplemented with N2, 1 mM dibutyryl cyclic adenosine 3’, 5’-
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monophosphate (cAMP), SHH (50 ng/mL), FGF8 (10 ng/mL) and Ascorbic acid (200 µM). 
Medium was replaced once every three days. Cells were harvested after 6 days. 
 
2.2.4a – Cell  cycle analysis by propidium iodide assay 
mes-c-myc-A1 cells infected with Nurr1, Lmx1a, Pitx3 or with rtTA virus alone were cultured 
to perform cell cycle analysis in two different conditions. In basal condition (B) cells were 
cultured for 3 days in a proliferative medium  (MEM/F12, 10% FBS, Pen/Strep) and the day 
after plating doxycycline (4 µg/mL) was added. To synchronize cell cycle cells were starved from 
serum for 48 h after plating and this condition is indicated as reloaded (R). During these days 
exogenous gene expression was activated by doxycycline administration (4 µg/mL). At 3DIV, 
FBS was added to re-start cell cycle. As positive control of cell cycle arrest, starved cells (S) were 
harvested at 3DIV from reloaded control samples before the serum reloading. 
To perform cell cycle analysis cells were trypsinized and washed in PBS by sequential 
centrifuged at 400 × g for 5’. Cell pellets were dissolved and fixed for 30’ in ice adding 1 mL of 
dropwise ice-cold 70% ethanol. After centrifugation and wash in PBS, cells were resuspended in 
250 µL of RnaseA (100 µg/mL, Roche) in PBS and incubated 30’ at 37°C. Then propidium 
iodide (PI; 20 µg/mL, Sigma-Aldrich) was added 30’ before samples processing with FACS BD 
Canto (Darzynkiewicz et al. 2001). 
 
2.2.5 – Embryonic stem cell  (ESC) 
R26CreER/+ mouse embryonic stem cells (Omodei et al. 2008) were used to generate ESC 
population line carrying stably exogenous genes 3xFlagNurr1_IRES-Cherry and/or Lmx1a-
V5HIS_IRES-GFP (ESCN-RED; ESCL-GFP; ESCNL-RED/GFP). Cells were cultured on gelatinized wells 
(0.1% Gelatine in PBS) in ESC medium: GMEM supplemented with 10% foetal calf serum 
(FCS), 1 mM sodium pyruvate, 1x non-essential amino acid (NEAA), 2 mM L-glutamine, 0.1 
mM β-mercaptoethanol, and 100 U/mL leukaemia inhibitory factor (LIF). ESC were plated at 
low density (8 × 103 cells/cm2) and infected after one day. 6 h after infection, exogenous genes 
were activated by dox administration (4µg/mL). Cells were sorted with FACS ARIA (BD Falcon), 
12 h after dox induction and plated in ESC medium dox-free at density of 7.5 × 103 /cm2. After 
amplification different population were differentiated to mesDA neurons. At this purpose cells 
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were plated at low density in N2B27 medium (half DMEM/F12 and half Neuro basal medium, 
supplemented with N2, retinol-free B27, 2 mM L-Glutamine, 0.05 mM β-mercaptoethanol) and 
cultured for 4 days. At DIV5 cells were splitted to reduce density on wells coated with solution of 
poly-D-lysine (two hours at 37°C) and then with a solution of Laminin (20 µg/mL in PBS for at 
least two hours). From DIV5 to DIV9, SHH (100 ng/mL or SAG 0.4 µM) and FGF8 (100 
ng/mL) were added to medium, while dox (4 µg/mL) was added only at DIV7. At DIV9, SHH 
and FGF8 was removed and ascorbic acid was added (200 µM). Cells were harvested at DIV14. 
 
2.2.6 - epiSCs 
epiSCs have been derived as described by Guo and colleagues (Guo et al. 2009). They are 
cultured in epiSC medium containing half DMEM/F12 and half Neuralbasal medium, 
supplemented with N2, retinol-free B27, 2mM L-Glutamine, 0.05 mM β-mercaptoethanol, 10 
ng/mL bFGF and 20 ng/mL Activin. Cells were splitted every 2-3 days as epiSC by using 
mechanical dissociation with 2mL serological pipet and plated in multiwell plates, coated with 
FCS for 30' at 37°C. For DA differentiation epiSCs were plated one day before the bFGF and 
Activin withdrawal in 12-wells plate, previously coated with a solution of 15 µg/mL Fibronectin 
for 30' at 37°C. One day later (DIV1), cells should reach 60 to 80% of confluence and at this 
point is possible to switch the medium from epiSC medium to simple N2B27 medium, that is 
epiSC medium but without bFGF and Activin. During these phases cells were infected with 
lentiviral particles as described in single experiments. At DIV2 cells where splitted and diluted on 
a new 12-wells plate previously coated with Fibronectin. From DIV5 to DIV9 cells were 
maintained in N2B27 medium supplemented with SHH (100 ng/mL or SAG 0.4 µM) and FGF8 
(100 ng/mL). Usually, at DIV9 N2B27 is supplemented with doxycycline (4 g/mL) and ascorbic 
acid (200 µM). Cells were cultured until DIV16. 
 
2.2.7 – Mouse embryonic fibroblasts (MEFs) 
Mouse embryonic fibroblast was used to transdifferentiate into DA neurons by over-expression 
of specific combination of transcription factors and miRNAs. MEFs were isolated from E14.5 
wild-type or TH-GFP knock-in mice embryos as previously described (Caiazzo et al. 2011). 
Briefly from embryos were removed head, vertebral column and all internal organs; the remaining 
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embryonic tissue was manually dissociated and incubated in 0.25% trypsin for 15'. Cells from 
each embryo were plated onto a 150 mm × 25 mm tissue culture dish in MEF media (DMEM, 
10% FBS, NEAA, sodium pyruvate and Pen/Strep). In all experiments cells were not splitted 
more than four times. To transdifferentiate MEFs in DA neurons cells were plated at density of 
25 × 103 cells/cm2 and infected after 24 h. 16 - 20 h after infection cells were switched into fresh 
MEF media containing doxycycline (4 μg/mL). After 48 h medium was replaced with neuronal 
inducing media (DMEM/F12, B27 and dox). Cells were harvested at DIV22. 
 
2.2.8 – Mouse adipose derived adult stem cells (ADAS) 
Adult mice were sacrificed to remove inguinal, and abdominal fat pads and digested in 
1mg/mL collagenase in HBSS for a 1 h at 37°C and 5% CO2. Tissue fragments were centrifuged 
two times at 400 g for 5’ to remove collagenase. Cells were plated for 1 h at 37°C in DMEM 
supplemented with 10% FBS, 25 mM HEPES, Pen/Strep, NEAA EGF (10 ng/mL) and bFGF 
(20 ng/mL). Then supernatant was transferred in new well in the same medium (Safford et al. 
2002). Differentiation in DA cells was achieved by infection with lentiviral particles carrying 
Ascl1, Nurr1 and Lmx1a and culturing cells in DMEM/F12 supplemented with N2 and dox for 
at least DIV12. 
 
2.3 – Molecular biology methods 
2.3.1 – RNA extraction, reverse transcription and real time  PCR 
RNA was extracted from cells using the TRI-REAGENT (Sigma-Aldrich) classic method as 
described by Chomczynski and Sacchi (Chomczynski et al. 1987). RNA was treated with 
DNAase-I (New England Biolabs, NEB) to eliminate possible DNA contaminations. The yield 
and the integrity of RNA were determined by spectrophotometric measurements and by agarose 
gel electrophoresis, respectively. For the reverse transcription 2 µg of RNA were incubated for 5' 
at 65°C with 6 μM random hexanucleotides (NEB) as primers in presence of 500 µM dNTP 
(Euroclone). Reverse transcription is performed with 200 U of Moloney’s murine leukemia virus 
reverse transcriptase (M-MuLV; NEB) in an appropriate buffer (50 mM Tris-HCl pH 8.3, 3 
mM MgCl2, 75 mM KCl, 10 mM DTT) supplemented with 40 U of human placenta derived 
RNase inhibitor (NEB). Samples were incubated in a thermal cycler at 25°C for 10', 42°C for 60' 
	   	   32	  
and finally at 90°C for 10' in order to denature RNA-cDNA hybrids. cDNA is diluted 1:5 in 
ddH2O prior to use. 
Analyses were carried out at least on triplicate samples for each experiment and they were 
processed separately. RT-PCR was performed on 4 μl of previously diluted cDNA (1:5) template 
using the Power Sybr Green Master mix (Applied Biosystem), in presence of 0.5 μM specific 
oligos. All oligos were designed using the Oligo7 software and are listed in Table 2.3 and were 
synthesized by Eurofins Genomics. The experiments were performed on a 7900 HT Fast Real 
time PCR system (Applied Biosystem) with a thermal profile consisted of 2’ at 50°C, 10’ at 95°C 
and 40 cycles of 15’’ at 95°C and 1’ at 60°C. Gene expression levels were quantified by the 
comparative threshold cycle (CT) method (Livak et al. 2001, Schmittgen et al. 2008) using 
hypoxanthine phosphoribosyl-transferase (HPRT) as an internal control gene (Pernas-Alonso et 
al. 1999). The fractional number of PCR cycles CT required to obtain a given amount of 
amplified product in the exponential phase of amplification was determined for the gene of 
interest and for HPRT in each cDNA sample. The relative expression level of the gene of interest 
was then expressed as 2 -ΔCT or as 2 -ΔΔCT where ΔCT= (CTGENE - CTHPRT) and ΔΔCT = 
(ΔCTSAMPLE – ΔCTCTRL). 
 
2.3.2 - miRVana RNA extraction and TaqMan® MicroRNA Assays 
Usual RNA purification strategies rely on organic extraction, followed by alcohol precipitation. 
These strategies, because of the alcohol precipitation, are inefficient in recovering small RNA 
forms. The miRVana miRNA isolation (Ambion) strategy uses organic extraction followed by 
purification on a glass fiber filter (GFF) under specialized binding and wash conditions. With this 
strategy all RNAs are recovered, from large mRNAs to ribosomal RNAs down to 10-mers small 
RNAs. 1 volume of cold sterile PBS was added to samples in RNA later. Samples were 
centrifuged, RNA later/PBS solution was removed and cell pellet was resuspended in the 
provided lysis buffer. Later, RNA was extracted following the manufacturer instructions. As last 
step, RNA was eluted in 100 μl of RNAase-free water, previously warmed at 95°C and then 
quantified by spectrophotometric analysis. For the TaqMan® MicroRNA Assays sample were 
further diluted to 2 ng/μl. Instead, for miQPCR samples were diluted to 10 ng/μl. 
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TaqMan® MicroRNA Assays (Applied Biosystem) is the most commonly used strategy to 
quantify miRNAs. This assay is based on a two-step process. First, a reverse transcription is 
performed starting from a miRNA specific stem&loop primer. Secondly, target amplification is 
obtained using a miRNA specific forward primer and a reverse primer able to bind the opened 
loop. Amplification levels detection is based on a TaqMan® miRNA specific probe conjugated 
with a fluorescent dye (FAM™ dye) on its 5’end and a non-fluorescent quencher on its 3’end. 
Moreover a minor groove binder (MGB) is conjugated too on the 3’end. It is a particular 
tripeptide that allows stabilizing the probe specific binding without increasing probe length. 
Briefly, reverse transcription (RT) for miR-218-5p, miR-124a, miR-34b/c, miR-204, miR-148 
and the reference snoRNA-202 was performed using the TaqMan® microRNA Assay provided 
RT primers for each of the listed miRNAs. The RT reaction was carried out with the suggested 
TaqMan® MicroRNA Reverse Transcription Kit (Applied Biosystem) using reagents and enzymes 
provided with the kit and following the protocol provided by the company. qPCR was performed 
using primers and probe provided with the miRNA specific TaqMan® microRNA Assay e with 
the TaqMan® Universal Master Mix II, no UNG (Applied Biosystem). To perform qPCR I 
followed the protocol provided by the manufacturer. The instrument was the 7900 HT Fast Real 
time PCR system (Applied Biosystems). 
 
2.3.3 – Western Blot analysis 
To verify the enrichment of TH protein, mE12.5-PCs cells differentiated into mesDA neurons 
by over-expression of Nurr1, Lmx1a and both, were lysed in Lysis Buffer (150 mM NaCl, 50 
mMTris-HCl pH7.4, 0.5 mM EDTA, 5 mM MgCl2, 0.5 mM DTT, 5% glycerol, 0.2% NP40 
and protease inhibitors). Proteins were extracted by centrifugation at 15000 g for 10’ 4°C. 
Protein concentration was measured at spectrophotometer by Bradford assay (Bradford 1976). 
Proteins were separated on 12% SDS-polyacrilamide gel and transferred to PVDF membranes 
(Millipore) as yet described (Speranza et al. 2013). Filters were probed for 2 h at room 
temperature or overnight at 4°C with the primary antibody (Tab. 2.4). After washing, 
immunoblots were incubated with secondary antibodies (1:10000, Amersham) and the reaction 
detected with the ECL plus procedure (Amersham). 
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GENE Fw oligo sequences (5’→3’) Rv oligo sequences (5’→3’) Aplicon size (base pair)  
Bdnf  ACAATGTGACTCCACTGCCG CACTCTTCTCACCTGGTGGAACT 70 bp 
Dat  TCTGGGTATCGACAGTGCCA GCAGCTGGAACTCATCGACAA 70 bp 
DBh  GACCGGCTACTGCACAGACAA GAGAGGCAAAGATGTGGATTCC 70 bp 
Gad2  AGGGTTACTGATGTCCCGGAA TCCATGTCACAGAGTTGGC 52 bp 
Gfap  GAGGGACAACTTTGCACAGGA CCAGCCTCAGGTTGGTTTCAT 70 bp 
Hprt  TGGGAGGCCATCACATTGT AATCCAGCAGGTCAGCAAAGA 71 bp 
Lmx1a  AACCAGCGAGCCAAGATGAA TGGGTGTTCTGTTGGTCCTGT 70 bp 
Nestin AGCAACTGGCACACCTCAAGA CTCAGCCTCCAGCAGAGTCC 71 bp 
Msx1  CTCCCCGCCCCCAGCCAGAC GGGCTTGCGGTTGGTCTTGT 53 bp 
Ngn2  ATCTGGAGCCGCGTAGGAT CATCAGTACCTCCTCTTCCTCCTT 70 bp 
Nurr1  CAACTACAGCACAGGCTACGA GCATCTGAATGTCTTCTACCTTAAT 98 bp 
Pitx3  GCAACTGGCCGCCCAAGG AGGCCCCACGTTGACCGA 83 bp 
pre-miR-204 AGATTCTCCCAGATTAACAAC AGAGCATCCACAGAAGGTAG 118 bp 
pre-miR-211 CAACCTATCAGGGCCGCACACT GATCAAGCCGGTCAGTATTCC 108 bp 
Pnmt  GTGTATAGTCAGCATGCCTGCC CGAAGCTGGCGTTCTTTCTC 70 bp 
c-Ret  TGAACCTACCCAGGGCCTACT GACTTTCCCGATCTGGGCAT 70 bp 
Sert  GGAACGAAGACGTGTCCGAG TGCCTCCGCATATGTGATGA 70 bp 
Sox2  AGGGCTGGACTGCGAACTG TTTGCACCCCTCCCAATTC 71 bp 
Th  CCTTTGACCCAGACACAGCA ATACGAGAGGCATAGTTCCTGAG 121 bp 
Tph2  GACCACCATTGTGACCCTGAA ACGGCACATCCTCGAGATCT 70 bp 
Trpm1 CTGCCTTGCTCAAAGGAACCAA GAGGGGCCAGGCGGCCCAG 138 bp 
Trpm3 CATGCACTCCCACTTCATCC TGGAACCCCTTGACCGATT 208 bp 
Tubb3  CGTGGGCTCAAAATGTCATC TGGCTGTGAACTGCTCCGAGAT 66 bp 
Vmat2  TTGCTCATCTGTGGCTGGG TGGCGTTACCCCTCTCTTCAT 91bp 
Table 2.3:  Oligos for real  t ime  PCR. 
 
2.4 - Microscopy and quantitative analyses 
2.4.1 - Immunocytochemistry 
After medium removal, cells were washed twice with PBS and then fixed with 4% 
paraformaldehyde (PFA; Sigma-Aldrich) in PBS for 30' at RT. Cells were permeabilized for 15 
min with PBS-0.1%Triton-X-100 (Sigma-Aldrich). Later, fixed cells were incubated in a 
blocking solution with 5% BSA (Sigma-Aldrich) and 10% of normal goat serum (NGS; Sigma-
Aldrich) in PBS for 1 h at RT and then incubated with primary antibody (the dilution was 
specific for each antibody), usually overnight at 4°C or 2 h at RT. Subsequently, cells were 
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washed three times in PBST, incubated 1 h at RT with fluorescence-labeled secondary antibody 
(1:400; Alexa Fluor®, Invitrogen). At the end, cells were washed again in PBS and counterstained 
with DAPI (1:1000; Invitrogen). As negative controls some cells were processed as described 
above, but without incubation with primary antibody. 
Images were acquired using a Leica DMI6000 inverted microscope at 10× and 20×. In order to 
compare pictures from the same set of experiments, images were taken keeping the same settings 
on the acquisition software (Leica Application Suite AF). For cell counting, the number of 
positive cells was quantified using a custom macro disposable in the ImageJ software. 
 
Epitopes Host species  Applications 
Working 
di lution Manufacturer 
Catalogue 
number 
TH Rabbit IF 1:500 Chemicon MAB318 
TH Mouse WB 1:500 Chemicon AB152 
Lmx1a Rabbit WB 1:4000 Millipore AB10533 
V5 Mouse IF 1:500 Invitrogen R960CUS 
Flag Rabbit IF/WB 1:1000 Sigma-Aldrich F7425 
Flag (M2) Mouse IF/WB 1:1000 Sigma-Aldrich F3165 
Ascl1 Mouse IF 1:500 BD Pharmingen 556604 
βIII-Tubulin Mouse IF 1:500 Covance MMS-435P 
β-Actin Mouse WB 1:10000 Sigma-Aldrich MAB1501 
Mouse IgG Sheep WB 1:10000 Amersham  NA931 
Rabbit IgG Donkey WB 1:10000 Amersham  NA934 
Mouse IgG Goat IF 1:400 Millipore AP124F 
Rabbit IgG Goat IF 1:400 Millipore AP132F 
Rabbit IgG Donkey IF 1:500 Jackson ImmunoResearch 711-605-152 
Table 2.4:  List  of  antibodies . 	  
 
2.4.2 – High-Content imaging 
Screening of miRNAs involved in DA induction was performed plating mE12.5-PCs in an 
optical 384-wells (Thermo scientific) as described above. The number of TH+ cells were 
automatically analyzed by cell-based High Content Screening (HCS) confocal microscope Opera® 
Phenix (Perkim Elmer). HCS is an analysis tool used to acquire, manage, and search multi-
parametric information regarding the composite phenotype of cells. In my experiments I acquired 
at least 270 areas per condition. 
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2.5 – Statistical analysis 
For all experiments, analysis of variance was carried out, followed by post hoc comparison 
(ANOVA, Dunnett’s or Newmann-Keuls test). A value of p ≤ 0.05 was considered significant. 
Data were expressed as mean ± SEM and show p values with special symbols. At least three 
independent replicates were used for RT-PCR and for cell counts. 
Analysis of High-Content data was performed on R software with one-way analysis of variance 
and Benjamini-Hocheberg’s post hoc test, after standardization of value. 
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3 - RESULTS 
 
Different types of neurons in the brain are interconnected to form the most complex network 
described in nature. In the brain, although all cell types are interspersed with each other every 
neuron maintains its individual phenotype. To recapitulate, in vitro, the processes that underlie 
neuronal development is obviously complex and require the identification of the factors involved, 
their right concentration and their application at a precise window of time. Moreover, often the 
same molecules can define the specification of different cell types depending by the surrounding 
trophic niche. 
To bypass these problems, over the years, the scientists tried to simplify the scheme that 
physiologically occurs in vivo by plating neurons precursor cells and studying the in vitro 
processes underlying neuronal differentiation. Nevertheless obtaining homogeneous populations, 
in vitro, remains still a difficult procedure. 
The aim of this work is to reproduce, in vitro, mesencephalic dopaminergic neurons (mesDA) 
development and to identify new players involved in this process. 
The data herein 1) describe a synergy between the two transcription factors Nurr1 and Lmx1a 
able to improve the differentiation and the maturation of the mesDA phenotype and 2) identify 
two microRNAs involved in DA development. 
 
 
3.1- Lmx1a synergizes with Nurr1 in the specification of mesDA phenotype 
Lmx1a is reported as transcription factor (TF) involved in early phases of DA induction 
(Andersson et al. 2006). Only in the last years it has been associated also to differentiation and 
maturation of mesDA neurons and in promoting transdifferentiation into DA cells (Chung et al. 
2012, Caiazzo et al. 2011). How Lmx1a mediates its function is still unclear. To dissect the role 
of Lmx1a in the developing midbrain, I over-expressed Lmx1a and Nurr1 in different cell types 
to generate mesDA neurons and to study the eventual synergy between these two TFs. 
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3.1.1 – Screening of transcription factors affecting mesDA differentiation 
To generate an in vitro dopaminergic model system, we isolated neural progenitor cells  
(NPCs) from midbrains of mouse embryos (E) at 12.5 gestational day. E12.5 is the time window, 
during midbrain development, where TH+ cells have been already generated (the process start at 
E9) but have not yet completed the differentiation phase. Indeed DA neuron maturation starts at 
around E13 (di Porzio et al. 1990), thus E12.5 is the time point where we expect to obtain the 
higher number of mesDA precursors not yet committed to differentiation that maintain 
responsiveness to differentiating factors.  
Based on these considerations, I dissected E12.5 midbrains from wild type (WT) and TH-GFP 
C57 BL/6 mice, a transgenic mouse line carrying the green fluorescent protein (GFP) under the 
control of TH promoter (Matsushita et al. 2002). 
 
 
Figure 3.1:  in vitro differentiat ion of midbrain neuroblasts .  
(A) Image of mouse embryo at E12.5 with schematic diagram of encephalic areas (red, 
telencephalon; yellow, diencephalon; green, mesencephalon; pink, metencephalon; cyan, 
myelencephalon; white: spinal cord).  
(B) Schematic protocol of in vitro mesDA differentiation of mE12.5-PCs cells (view Materials 
and Methods section for further details). 
 
Midbrain-derived NPCs were plated at low density (≈	   4 × 104 cells/ cm2) in proliferative 
medium in order to expand pluripotent cells. During this phase, ventral-midbrain commitment 
was induced by the addition of the morphogens SHH (50 ng/mL) and FGF8 (10 ng/mL). After 
six days in vitro (DIV6) SHH, FGF8 and bFGF were replaced by ascorbic acid (200 µM) to 
promote neuronal survival and differentiation. By using this basic protocol we were able to 
identify in the culture dish TH+ cells (Volpicelli et al. 2004); however their amount was still too 
low to perform functional studies. In order to implement the amount of TH+ cells, I over-
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expressed specific pro-dopaminergic transcription factors by using inducible lentiviral vectors as 
described in Matherial and Methods section (Fig. 3.1).  
The reason why I approached the lentiviral system is that, differently from classical transfection 
protocols, such as Lipofectamine, it allows high efficiency of infection in non-dividing primary 
cultures, thus generating higher number of cells expressing the gene of interest. To this purpose I 
used inducible lentiviruses that allow controlling over time the expression of the transfected gene 
by adding doxycycline to the culture media (see Material and Methods section).  
 
 
Figure 3.2:  Screening of pro-dopaminergic transcription factors.  
(A)  The diagram shows real time PCR evaluation of exogenous genes expression induced by 
doxycycline in mE12.5-PCs infected with lentiviral particles carrying 3xFlag-Nurr1 (LV-N), Pitx3 
(LV-P), Lmx1a-V5HIS (LV-L) and their combinations. The mRNA fold increse of interest genes 
were normalized on the housekeeping gene level (Hprt), and compared to the average of control 
(Ctrl=1; 2-ΔΔCT method). Bars represent mean ± SEM of quadruplicated samples. 
(B)  The diagram shows the TH mRNA level in mE12.5-PCs infected as previously described. 
TH mRNA level were normalized on the Hprt mRNA (2-ΔCT method). Bars represent mean ± 
SEM of quadruplicated samples. * p ≤ 0.05 respect Ctrl ;  ** p ≤ 0.01 respect Ctrl.  
p values were calculated after one-way analysis of variance and Dunnett’s post hoc test to compare 
all columns to control. 
 
 
In detail, during the proliferative stages at DIV3, midbrain E12.5 primary cultures (mE12.5-
PCs) were infected with inducible lentiviral particles carrying the transcription factors Nurr1 
(tagged at N-terminus with 3xFLAG peptide), Lmx1a (tagged at C-terminus with V5-HIS) and 
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Pitx3. The infected cells were amplified for other 3DIV and the transcription factors expression 
was induced by the addition of doxycycline (4 µg/mL) at DIV6, when the differentiation was 
induced. The efficiency of infection was evaluated by real time PCR and immunostaining 
indicating that more than 70% of cultured cells was infected (data not shown) expressing higher 
levels of exogenous genes if compared to non-infected cells (Fig. 3.2A). To evaluate if our 
experimental conditions allowed maturation of dopaminergic precursors, I measured by real time 
PCR the expression of TH at DIV12 in different conditions. As shown in figure 3.2B, the over-
expression of Nurr1 increases TH mRNA levels compared to control, while Lmx1a and Pitx3 do 
not affect TH expression. Interestingly, the combination of Nurr1 with Lmx1a improves the 
yield of TH+ cells if compared to Nurr1 alone (Fig. 3.2B). Surprisingly, I did not obtain any 
effect, in term of TH expression, when Pitx3 was combined with Nurr1, suggesting that addition 
of Pitx3 does not influence DA differentiation but probably acting mainly as a pro-survival factor 
(see Introduction). 
These preliminary observations allowed to set up a model system and to select the transcription 
factors most appropriate to recapitulate in vitro mesDA development. 
 
3.1.2 - Lmx1a synergizes with Nurr1 to regulate TH expression 
Starting from these data, I chose to further investigate the interaction of Nurr1 and Lmx1a 
during in vitro mesDA differentiation. Lentiviral over-expression of Nurr1 is able to induce 10 
times higher levels of TH mRNA when compared to control (Fig. 3.3A) similarly to what 
previously described (Zhou et al. 1995). Interestingly, over-expression of Lmx1a alone does not 
affect TH mRNA levels, but potentiates Nurr1 activity with a 15-fold increase with respect to 
control, when co-expressed with Nurr1 (Fig. 3.3A).  
To verify if similar differences were observed also at protein levels I performed western blot 
analysis for TH. As shown in figure 3.3B-C, Nurr1 over-expression increases two times TH 
protein expression while the combination Nurr1-Lmx1a triplicates TH level if compared to 
control (Fig. 3.3B-C).  
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Figure 3.3:  TH up-regulation in mE12.5-PCs over-express ing Nurr1 and Lmx1a. 
(A) The diagram show the TH mRNA level in differentiated mE12.5-PCs over-expressing 
Nurr1, Lmx1a or both. TH expression were normalized on Hprt mRNA and compared to control 
(Ctrl=1; 2-ΔΔCT method). Bars represent mean ± SEM of quadruplicated samples. * p ≤ 0.05 relative 
Ctrl and Lmx1a;  ** p ≤ 0.01 relative to Ctrl and Lmx1a and p ≤ 0.05 relative to Nurr1. p values 
were calculated after one-way analysis of variance and Newmann-Keuls post hoc test to compare all 
pairs of columns. 
(B)  Western blotting images of differentiated mE12.5-PCs over-expressing 3xFlag-Nurr1 (LV-
N), Lmx1a-V5HIS (LV-L) or both (LV-NL). Nurr1 protein over-expression was evaluated by 
rabbit anti-Flag antibody, TH protein by mouse anti-TH and β-actin by anti-mouse β-actin. 
(C)  Quantitation of TH proteins. Bars represent the densitometric values of TH western blot 
signals normalized with those of β-actin in the same samples and compared to the control 
indicated as dotted line (Ctrl = 1; mean ± SEM; n = 3). 
 
I also analyzed TH expression by immunofluorescence. At DIV12 differentiated mE12.5-PCs 
express Tuj1; however they form clusters of cells (Fig. 3.4A) that makes it more difficult to 
quantify the percentage of mesDA neurons. To bypass this problem, I combined 
immunofluorescence analysis with high-contents automated confocal microscopy to acquire high-
resolution images from an extended area  (270 images for each condition) that allow counting of 
TH+ cells. This analysis revealed that the combined over-expression of Nurr1+Lmx1a increased 
the number of TH+ cells doubling the effect of the single over-expressing Nurr1 (Fig. 3.4A-B).  
These data suggest a potential cooperation between the transcription factors Lmx1a and Nurr1, 
at least as regulator of TH expression. 
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Figure 3.4:  Nurr1 and Lmx1a increase the number of TH+ cel ls .  
(A)  Differentiated mE12.5-PCs over-expressing Nurr1 and Lmx1a were immunostained with 
specific antibodies against the neuronal marker βIII-tubulin (anti-Tuj1 in red) and TH (green). 
Images were acquired with DMI6000 Leica microsystems at 20x magnification. 
(B)  The bar plot represents the percentage of cells immunopositive for the nuclear marker 
DAPI and for the antibody anti-TH. Means ± SEM; n = 270 ± 12; * p ≤ 0.05 relative to Ctrl and 
Lmx1a;  ** p ≤ 0.01 relative to Ctrl and Lmx1a and  p ≤ 0.05 respect Nurr1. p values were calculated 
after one-way analysis of variance and Newmann-Keuls post hoc test to compare all pairs of columns. 
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3.1.3 - Over-expression of Lmx1a and Nurr1 promotes maturation of 
midbrain neurons 
To verify whether the over-expression of Nurr1 with Lmx1a effectively promotes mesDA 
differentiation, I analyzed the levels of expression for other DA markers in differentiating 
mE12.5-PCs. Over-expression of Nurr1 (LV-N or LV-NL) up-regulated the mRNA levels for 
Pitx3, Vmat2, Dat, GDNF receptor (c-Ret) and Bdnf (Fig. 3.5A). Lmx1a potentiates the effect of 
Nurr1 on Vmat2, other than Th. Lmx1a alone had no effects on any of these genes but controls 
the expression of Msx1 and Ngn2, already described as direct targets (Fig. 3.5A; Yan et al. 2011, 
Hong et al. 2014). 
 
 
Figure 3.5 (previous page) :  Characterization of mE12.5-PCs over-express ing 
Nurr1 and Lmx1a. 
Real time PCR analysis of dopaminergic (A) and non-dopaminergic (B) genes in mE12.5-PCs after 
infection with lentiviral particles carrying Nurr1 (orange), Lmx1a (pink) and both (blue). In (B) 
values of the mRNA genes were normalized on that of Hprt (2-ΔCT method) and in (A) compared to 
average of control points (2-ΔΔCT method). Means ± SEM, n = 6.  
* p ≤ 0.05 between Nurr1 or Nurr1+ Lmx1a respect Ctrl; ♮ p ≤ 0.05 between Lmx1a respect Ctrl; 
‡ p ≤ 0.01 between Ctrl and all other samples. p values were calculated after one-way analysis of 
variance and Dunnett’s post hoc test to compare all columns to control. 
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At the same time, Nurr1 and Lmx1a reduced Gfap expression (marker of glial and precursor 
cells; Fig. 3.5B), suggesting that these two TFs promote pro-neuronal differentiation. 
Remarkably, the neuronal phenotype obtained is dopaminergic-specific, as revealed by almost 
undetectable levels of others catecholaminergic markers such as DBH and PNMT and 
serotonergic markers (SERT and TPH2; Fig. 3.5B). In culture few GABA-like cells were present 
and Nurr1 and Lmx1a reduced the mRNA levels of GABAergic marker GAD65. 
Therefore mE12.5-PCs differentiate in mesDA neurons through the over-expression of Nurr1 
and Lmx1a, resulting a good in vitro model to study the mesDA phenotype. 
 
3.1.4 - Pro-mesDA effects of Lmx1a and Nurr1 co-expression in mes-c-myc-A1 
cell  l ine. 
Starting from the protocol described on mE12.5-PCs I also used the murine mesencephalic cell 
line mes-c-myc-A1 to generate DA cells. These cells have been already characterized for their 
commitment to the dopaminergic phenotype (A1; Colucci-D’Amato et al. 1999) and have been 
used as an alternative model to recapitulate dopaminergic differentiation. In details, A1 cells were 
plated at low density in presence of SHH (50 ng/mL) and FGF8 (10 ng/mL). At DIV2 cells were 
infected with the inducible lentiviral vectors carrying Nurr1 and/or Lmx1a (LV-N and LV-L) and 
at DIV4 differentiation was induced by activation of exogenous genes with doxycycline. After 10 
days (DIV14), cells were harvested to perform mRNA and IF analysis. First of all the efficiency of 
over-expression was verified by real time PCR (data not shown); as expected differentiated A1 
express βIII-tubulin also in control (Fig. 3.6A). Over-expression of Nurr1 alone or in 
combination with Lmx1a decreased Gfap, Nestin and Sox2 expression therefore boosting neuronal 
differentiation (Fig. 3.6A). Similarly to mE12.5-PCs, Lmx1a alone did not influence Gfap level 
and increased Sox2 mRNA. The evaluation of mesDA markers shows that similarly to primary 
cultures, Nurr1 alone or in combination with Lmx1a increased both TH mRNA levels (Fig. 
3.6B) and the number of TH+ cells (Fig. 3.6C) if compared to control samples. Moreover the TH 
mRNA enrichment in A1 cells was higher of that observed in primary cultures, most probably 
due to the very low levels of TH in undifferentiated A1 cells respect to primary cultures. Similarly 
to primary cultures, the over-expression of Lmx1a enhances the action of Nurr1 on TH 
induction, supporting the hypothesis of a cooperative action between the two factors. The up-
regulation was observed also for Vmat2 and Dat genes, even if in A1 cells Lmx1a alone was able 
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to increase the mRNA levels for Dat. These data confirm that A1 cells behave in part differently 
from primary cultures. Most probably they are more responsive to transcription factors since they 
have been engineered to constitutively express c-myc.  
 
 
 
Figure 3.6:  Characterization of mes-c-myc-A1 over-express ing Nurr1 and Lmx1a. 
Real time PCR analysis of neuronal and glial marker (A) and cathecolaminergic genes (B) in 
mE12.5-PCs after infection with lentiviral particles carrying Nurr1 (orange), Lmx1a (pink) and 
both (blue). mRNA genes levels are normalized on that of Hprt and compared to average of 
control points represented as dotted line (Ctrl=1; 2-ΔΔCT method). Bars represent means ± SEM, n = 
5. * p ≤ 0.05 of samples compared to control. ** p ≤ 0.05 between linked samples and of both with 
control. ‡ p ≤ 0.05 of all samples compared to control. ♮ p ≤ 0.05 with others samples. p values 
were calculated after one-way analysis of variance and Newmann-Keuls post hoc test to compare all 
pairs of columns. 
(C) Immunofluorescence analysis of A1 over-expressing Nurr1, Lmx1a or both (N+L). 
Exogenous Nurr1 was stained in red (anti-3xFlag). TH was marked in green. Pictures displays also 
phase contrast images and DAPI staining. 20x magnification. 
 
 
 
	   	   46	  
3.1.5 – Nurr1 promotes mesDA maturation arresting the cell  cycle in mes-c-
myc-A1 
Mature neurons are mitotically quiescent (G0 phase of cell cycle). To understand if Nurr1 
could promote neuronal differentiation by arresting cell cycle progression, I performed a cell cycle 
assay with propidium iodide in A1 cells over-expressing the transcription factors Nurr1, Lmx1a 
and both or Pitx3. In basal condition only ¼ of cells were in mitotic phase (G0/G1: 57% - 
G2/M: 24% - S: 19%; Fig. 3.7B). While over-expression of Lmx1a did not affect this 
distribution (G0/G1: 60% - G2/M: 21% - S: 19%; Fig. 3.7B), Nurr1 over-expression reduced 
the mitotic population at less than ⅕ (G0/G1: 67% - G2/M: 17% - S: 16%; Fig. 3.7B). Similar 
effects were recorded with the over-expression of Pitx3, a post mitotic factor (G0/G1: 71% - 
G2/M: 15% - S: 14%; Fig. 3.7C) or after 48 hours serum withdrawal (G0/G1: 75% - G2/M: 
13% - S: 12%; Fig. 3.7C). Interestingly, over-expression of Nurr1 prevented re-entry into cell 
cycle (Nurr1-R : G0/G1: 75% - G2/M: 13% - S: 12%; Fig. 3.7C). These results confirm that 
upon Nurr1 expression A1 cells definitely exit from cell cycle and become quiescent mature 
neurons. Interestingly cells expressing Pitx3 behave in similar way. 
 In my opinion, Nurr1 determines neural maturation by promoting cell cycle arrest. Most 
probably this occurs regulating cyclin-dependent kinases inhibitors like that already reported for 
p57kip2 (Joseph et al. 2003). I am actually planning to analyze different cyclins. 
 
3.1.6 – Functional analysis of different Nurr1 domains 
3.1.6a  – C-terminus domain of Nurr1 is not necessary to Lmx1a cooperation 
To better characterize the nature of the functional interaction between Nurr1 and Lmx1a I 
evaluated the activity of two truncated form of Nurr1 deleted for the N-terminal and C-terminal 
domain named respectively ∆Nter-Nurr1 and ∆Cter-Nurr1 (Fig. 3.8A). To this purpose we 
generated lentiviral particles carrying the truncated forms as well as a mutant transcriptionally 
inactive named Nurr1C280A/E281/A. As shown in figure 3.8B, both ∆Nter-Nurr1 and 
Nurr1C280A/E281/A were transcriptionally inactive in mE12.5-PCs. Differently, the over-expression 
of ∆Cter-Nurr1  increased significantly TH mRNA (Fig. 3.8B) and retained the ability to boost 
TH expression when over-expressed with Lmx1a, as observed for the combination Lmx1a-Nurr1 
(Fig. 3.8B-C). 
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Figure 3.7 (next page) :  Nurr1 promotes the cel l  cycle arrest .  
(A) Experimental design for cell cycle analysis with propidium iodide assays in mes-c-myc-A1 
cells. In basal condition (B) cells were cultured for 3 DIV in presence of serum and doxycycline to 
express exogenous genes. The reloaded sample (R) were starved from serum for 48 h to syncronize 
cells at G1 phase and then cell cycle was reactivated with serum addiction for 24 h. The control 
point starved (S) was harvested like R  samples without serum addiction. 
(B) Cell cycle analysis of cells over-expressing Nurr1, Lmx1a and Pitx3 in B . 
(C) Cell cycle analysis of cells over-expressing Nurr1, Lmx1a and Pitx3 in R and S  control 
point. 
 
These data demonstrate that: 1) the N-terminus domain of Nurr1 is necessary to its 
transcriptional activity (as also described by Nordzell et al. 2004); 2) the interaction with the 
DNA is highly specific and just two aminoacidic substitutions in the DNA binding domain are 
crucial to lose its function; 3) the interaction of Lmx1a with Nurr1 does not require physical 
binding to the C-terminus domain of Nurr1, reported as potential ligand binding domain; 4) the 
cooperation between Nurr1 and Lmx1a could be directed or mediated by a third factors. 
To better describe how Lmx1a synergizes with Nurr1, we performed Co-IP and ChIP analysis. 
Unfortunately, co-immunoprecipitation was unsuccessful most probably due to poorly efficient 
antibodies. Instead the results obtained by performing chromatin immunoprecipitation were 
promising (data not shown), however there was limited enrichment when we immune-
precipitated the chromatin-antigen complex, probably due to the relative low amount of mesDA 
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differentiated cells. To bypass this problem, we generated stem cells (ESCs) stably expressing 
fluorescent Nurr1 and Lmx1a alone or in combination (see below). 
 
Figure 3.8 (previous page) :  Activity of  truncated forms of Nurr1 on TH 
regulation. 
(A)  Schematic representations of Nurr1 truncated forms. 
(B)  Real time PCR evaluation of TH expression in mE12.5-PCs after infection with lentiviral 
particles carrying truncated forms of Nurr1 ± Lmx1a as reported in the legend. Values of TH 
mRNA were normalized on Hprt. Means ± SEM, n = 12. * p ≤ 0.05  between the samples and p ≤ 
0.01 compared to Ctrl. p values were calculated after one-way analysis of variance and Newmann-
Keuls post hoc test to compare all pairs of columns. 
(C)  Linear correlation between TH mRNA and exogenous Nurr1 mRNA. Values of 2-ΔCT for 
the two genes in the same samples were blotted to generate linear regression.  Values of R2 ≥ 0.5 
indicate that the regression lines fit the data with meaningfulness. 
The slopes of inactive forms of Nurr1 are almost near the zero (minactives+Lmx1a = 0.0008, minactives = 
0.0007), while the addition of Lmx1a to Nurr1 or ∆Cter-Nurr1 increases the slope of those points 
(mNurr1 = 0.007, mNurr1+Lmx1a = 0.016, m∆Cter = 0.005, m∆Cter +Lmx1a = 0.015; Fig. 3.8E). 
 
3.1.6b – Subcellular localization of ∆Cter-Nurr1 and ∆Nter-Nurr1  
To verify whether ∆Cter-Nurr1 and ∆Nter-Nurr1 proteins have different sub-cellular 
localization, I expressed the truncated forms and performed immunofluorescence in HEK293T, 
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mE12.5-PCs and A1. Surprisingly, while the transcriptionally inactive ∆Nter-Nurr1 was mainly 
located into the nucleus similarly to the full-length Nurr1, the transcriptionally active ∆Cter-
Nurr1 had an unexpected cytosolic distribution (Fig. 3.9). This data contrast what alreasy 
described previously (García-Yagüe et al. 2013) where two motifs in the C-terminus domain 
named nuclear exporting signals (NES1 and NES2) absent in our ∆Cter-Nurr1, have been shown 
essential for cytoplasmic translocation. This interesting result will be further investigated in future 
additional experiments, in order to exclude potential artifacts and to find a biological explanation. 
It will be useful however to understand how the cytoplasmic ∆Cter-Nurr1 promotes DA 
differentiation. At present the easier explanation is that a small amount of the protein localizes in 
the nucleus, being enough to promote TH transcription. 
 
Figure 3.9:  Sub-local izat ion of truncated form of Nurr1. 
Panel shows over-expressed truncated forms of Nurr1 in mE12.5-PCs, A1 and HEK293T cells, 
revealed with anti-3xFlag antibody in red. Live cells were stained with the DAPI. Yellow arrows 
evidence the cytosolic localization of ΔCter-Nurr1 compared to ΔNter-Nurr1 or full length Nurr1. 
The different morphology of HEK293T cells shows a perinuclear localization of ΔCter-Nurr1. 
DMI600 20x magnification. 
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3.2 – Identification of microRNAs involved in dopaminergic development 
The cellular model here defined has been extremely useful to identify novel players in 
dopaminergic transmission.  
In the last years a great attention has been dedicated to the role that non-coding RNAs play in 
neuronal differentiation. Among these, particular attention is paid on microRNAs, is mainly due 
to their potential use as therapeutic molecules (Junn et al. 2012). In addition, miRNAs could be 
really useful to easily modulate developmental processes and physiological conditions, or to 
ameliorate DA modeling. Actually, knowledge of their involvement during mesDA development 
is very limited (Baek et al. 2014). I focused my work on a specific group of microRNAs that have 
been identified in my host laboratory, because involved in the differentiation of epiSCs into 
mesDA neurons (De Gregorio et al. unpublished), I thus evaluated if over-expression of these 
miRNAs influences the differentiation of mesDA neurons and if they are modulated by Nurr1 
and Lmx1a. 
 
3.2.1 – miR-218-1 increases the number of TH+ cells  in mE12.5-PCs 
To evaluate if any of the candidate miRNAs could have a role in the development of DA 
phenotype, I over-expressed each candidate by lentiviral particles in mE12.5-PCs in presence or 
in absence of Nurr1 and analyzed the number of TH+ cells by High-Content confocal 
microscopy. As shown in Fig. 3.10, only the over-expression of miR-218-1 in combination with 
Nurr1 significantly enhanced the activity of Nurr1, increasing the number of TH+ cells. This 
effect is similar to that observed over-expressing Nurr1 with Lmx1a. miR-218-1 alone had no 
effect on TH+ cells compared to control (data not shown).  
miR-34b/c, miR-148a and miR-210 showed a trend similar to that of miR-218-1 (Fig. 3.10). 
Although the increment in term of TH+ cells observed upon their over-expression was not 
significant (Tab. 3.1), we cannot completely exclude their involvement in dopaminergic 
differentiation. They may represent a research objective in future projects. 
Others analyzed miRNAs (miR27, miR29, miR-132, miR204, miR219, miR-370, miR-375 
and miR-494) did not affect the number of TH+ cells (Fig. 3.10) in the same experimental 
conditions.  
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Figure 3.10: miRNA-218-1 enhances the activity of  Nurr1 in the induction of 
TH expression. 
High-content screening of miRNA’s activity on the number of TH+ cells after over-expression of 
Nurr1 in mE12.5-PCs derived from TH-GFP mice. GFP+ cells were counted at automated 
confocal microscope Opera and normalized on 3xFlag+ cells. Means ± SEM, n = 270 ± 60. * p ≤ 
0.05  of the samples respect to the control. p values are reported in Tab. 3.2. 
 
 
Table 3.1:  miRNA-218-1 enhances the activity of  Nurr1 in the induction of TH 
expression. 
p values derived from statistical analysis on high-content screening of miRNA’s activity on the 
number of TH+ cells.  p values reported in the table below were calculated after one-way analysis of 
variance and Benjamini-Hocheberg’s post hoc test to compare all samples. 
 
3.2.2 – Lmx1a over-expression up-regulates miR-204 in epiSC-derived mesDA 
neurons  
In parallel I tried to identify if any correlation exists between the TFs Nurr1 and Lmx1a and 
the class of miRNAs we identified. To this purpose we over-expressed Nurr1 and/or Lmx1a in 
differentiating epiSCs (Fig. 3.11; see Materials and Methods section) and we analyzed their effect 
on the expression level of few potentially interesting miRNAs (Fig. 3.12). By performing this 
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experiment, we observed that miR-204 was significantly up-regulated after over-expression of 
Lmx1a (alone or in combination with Nurr1; Fig. 3.12C) 
 
Figure 3.11: Characterization of epiSCs-derived DA cel ls .  
(A)  Real time PCR evaluation of the expression of dopaminergic markers in epiSCs over-
expressing Nurr1 (orange), Lmx1a (pink) and both (blue). Values of the mRNA genes are 
normalized on the housekeeping gene levels Hprt, and compared to average of control points 
represented by dotted line (Ctrl=1; 2-ΔΔCT method). Bars represent means ± SEM, n = 5. * p ≤ 0.05 
of samples compared to control. ** p ≤ 0.05 compared to all samples. p values were calculated after 
one-way analysis of variance and Newmann-Keuls post hoc test to compare all pairs of columns. 
(B) Representative images of TH+ cells derived from epiSCs over-expressing Nurr1 and/or 
Lmx1a and differentiated for 16 days. DMI6000 20x magnification. 
 
Interestingly this up-regulation was specific for miR-204 and not for its homologous miR-211, 
as revealed by semi-quantitative PCR that discriminates the two pre-miRNA sequences. As shown 
in Fig. 3.12E, pre-miR-204 was up-regulated after Lmx1a over-expression, while pre-miR-211 
was detected at very low levels. Since miR-204 is located intronically in the gene coding for 
Trpm3 (while miR-211 is intronic to Trpm1) we also analyzed if the expression of these two 
genes was affected by the over-expression of Lmx1a. As expected, Trpm3 was up-regulated by 
Lmx1a, while the expression of Trpm1 was detected at constant and very low level, independently 
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on Lmx1a over-expression (Fig. 3.12E). This result was confirmed also in mE12.5-PCs (Fig. 
3.12F) and suggests a potential direct regulation of miR-204 by Lmx1a. 
 
 
Figure 3.12: Analysis  of  miRNAs expression in  epiSCs-derived DA neurons.  
(A-D) qPCR analysis of the expression of several mature miRNAs after over-expression of Nurr1 
(cyan), Lmx1a (red) or both (blue) in differentiating epiSCs. RNA samples were harvested at 
DIV16, 8 days after induction of exogenous genes with doxycycline. miRNA specific Taqman 
probes were used to perform qPCR. All qPCR data are normalized to the average of the reference 
small nucleolar RNA 202 (sno-202). Data represent means ± SEM; n = 4. . * p ≤ 0.05 respect Ctrl; 
p values are calculated after one-way analysis of variance and Dunnett’s post hoc test to compare all 
columns to control. (A) miR-34b/c; (B) miR-124a; (C) miR-204; (D) miR-218-1.  
(E-F) Real time PCR analysis of pri-miR-204 and pri-miR-211 and their host genes Trpm3/1 in 
epiSCs (E) and mE12.5-PCs (F) over-expressing Nurr1 (cyan), Lmx1a (red) or both (blue). 
mRNA levels are normalized on the mRNA of Hprt (2-ΔCT method). Data represent means ± SEM; 
n = 6. * p ≤ 0.05 respect Ctrl; p values are calculated after one-way analysis of variance and 
Dunnett’s post hoc test to compare all columns to control. (G) Legend of color scheme. 
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No other significant variation in the expression of miRNAs analyzed was clearly detected, 
though miR218-1 and its host gene Slit2 seemed barely increased (Fig. 3.12D and data not 
shown), while the small increase in miR-34b/c upon Lmx1a over-expression could be a unspecific 
effect mainly caused by the low levels of the miRNA itself (Fig. 3.12A). 
To better characterize the effect of Lmx1a on miR-204 up-regulation, I used inducible ES cells, 
over-expressing Lmx1a (see below). 
 
3.2.3 - Generation of ES cells  over-expressing Nurr1 and/or Lmx1a 
To better appreciate the increase of miR-204 after Lmx1a over-expression I decided to generate 
mouse embryonic stem cells expressing an inducible lentiviral construct for Lmx1a. To this 
purpose, ESC cells were plated at low density (≈ 8 × 103 cells/ cm2) and infected with lentiviral 
vectors carrying for inducible Nurr1 and/or Lmx1a genes tagged with short peptides and 
conjugated with red and green fluorescent protein (3xFlag-Nurr1_IRES-Cherry and Lmx1a-
V5/HIS_IRES-GFP). Following this approach, fluorescent cells (Cherry+/GFP-, Cherry-/GFP+ 
and Cherry+/GFP+) were sorted and collected in doxycycline-free medium, in order to turn off 
exogenous expression. After 3 passages, cells were ready for mesDA differentiation in N2B27 
medium for 14 days with SHH agonist SAG, FGF8, doxycyxline and ascorbic acid (further 
details in Materials and Methods section) and finally collected for mRNA analysis. I am currently 
analyzing miR-204 and mesDA markers expression. The advantage of this approach is that the 
analyses were performed on  a homogeneous population of cells, thus reducing side effects caused 
by cellular heterogeneity. 
The generated cells will be useful to better dissect the previously described synergy between 
Nurr1 and Lmx1a: comparing ES cells co-expressing Nurr1 and Lmx1a (ESCNL-RED/GFP) with co-
cultured single-expressing cells (co-cultured ESCN-RED with ESCL-GFP), I will be able to 
discriminate if synergy is intercellular or intracellular. In both cases, the homogeneous population 
can be useful to perform ChIP and CoIP analysis to better characterize the mechanisms 
underlying the observed cooperation between the two TFs.  
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3.2.4 – Reprogramming into mesDA neurons by miRNAs over-expression 
Nurr1 plus Lmx1a can generate mesDA-like cells from neural precursors (mE12.5-PCs and 
A1) and from epiSC or ES cells. On the other hand, miR-218-1 and miR-204 could be involved 
in mesDA phenotype. To verify this hypothesis and to further confirm the synergy between 
Nurr1 and Lmx1a, I transdifferentiated mouse embryonic fibroblasts (MEFs) and mouse adipose 
derived adult stem cells (ADAS) into mesDA-like cells using Nurr1/Lmx1a in combination with 
specific miRNAs (see Materials and Methods section).  
The ability to transdifferentiate into DA neurons any other cell type can be useful for study in 
vitro pathological conditions involved in DA population generating DA-like cells from affected 
patients. In addition, if a specific miRNA is crucial to transdifferentiation, it could be a potential 
therapeutic target. 
In agreement with previous observations (Caiazzo et al. 2011) to transdifferentiate into neurons 
cells yet committed to other phenotype, I added the pro-neuronal transcription factor Ascl1 (or 
Mash1) to all experimental points. Indeed, preliminary data on MEFs show that single over-
expression of Nurr1 or Ascl1 did not affected TH expression, confirming unpublished data 
(Piscopo et al. unpublished).  
 
 
Figure 3.13: DA transdifferentiat ion from ADAS. 
(A)  Real time PCR analysis of transdifferentiating ADAS over-expressing Nurr1 (cyan), Lmx1a 
(red) or both (blue). (B) Magnification on TH mRNA expression. mRNA levels are normalized on 
the mRNA of the housekeeping gene Hprt (2-ΔCT method). Data represent means ± SEM; n = 5. * p 
≤ 0.05 respect to Ctrl; ** p ≤ 0.05 respect to all samples. p values are calculated after one-way 
analysis of variance and Newmann-Keuls post hoc test to compare all pairs of columns. 
 
 
 
Interesting, TH and Tuj1 expression was measured on ADAS and MEFs after over-expression 
of transcription factors Ascl1, Nurr1 and Lmx1a (ALN). As showed in Fig. 3.14A neuroblast and 
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neuronal markers were increased (Nestin, Sox2, Tuj1) in ADAS over-expressing ALN. 
Importantly TH mRNA was increased in AN (Ascl1 + Nurr1), and the addition of Lmx1a (ALN) 
potentiates this effects (Fig. 3.14B) corroborating previous data. Starting from these observations, 
I will analyzed the effect of over-expressing specific miRNAs together with AN and ALN in 
ADAS. 
In parallel preliminary data obtained on transdifferentiated MEF confirmed that the miR-218-
1 enhances the activity of Nurr1 in term of total amount of TH+ cells. Indeed after over-
expression of Nurr1 with Ascl1 (AN), 50% of Tuj1+ cells are also TH+. This effect is boosted at 
60% when miR-218-1 was added to the TFs (Fig. 3.15). 
 
 
 
Figure 3.14: miR-218-1 trans-differentiate MEF into TH+ cel ls .  
(A-B) Exemplificative images of MEF derived from TH-GFP mice transdifferentiated into mesDA 
neurons after over-expression of Ascl1+miR-218-1 (A) or Ascl1 + Nurr1 + miR-218-1 (B). Green 
= TH, red = Tuj1, blue = DAPI. 20x magnification. 
(C) Percentage of TH+ cells on Tuj1+ cells. Means ± SEM, n = 13. * p ≤ 0.05 respect Ctrl; ** p ≤ 
0.05 respect all samples. p values are calculated after one-way analysis of variance and Newmann-
Keuls post hoc test to compare all pairs of columns. 
  
	   	   57	  
4 – DISCUSSION 
 
Brain	  is one of the most fascinating structures in nature. In human being it is composed of 
about 1011 neurons interspersed with 10 times more glial cells (Azavedo et al. 2009). Neurons 
communicate between themselves by generating 9 trillions of synapses and represent the most 
complex network known in nature.  
The functions of this complex network allow defining the brain as a "living calculator", able to 
provide answers to every day life problems in few milliseconds.	  During the evolution brains 
evolved by committing different nuclei of the Central Nervous System to specific tasks in order to 
better answer to individual requirements aimed to species preservation. Of course there is the 
involvement of several brain areas for complex tasks and cognition. 
Among these regions, the midbrain appears as one of the most interesting structure since the 
dopaminergic neurons, here located, are involved both in primitive brain functions and in 
emotional and motivational behavior. Thus, the dopaminergic fibers generate a “bridge” that 
integrates primordial stimuli higher with functions, such as the reward responses of the limbic 
system. Alterations of midbrain circuits are involved in severe neurological and psychiatric 
disorders. 
How specific classes of neurons acquire their phenotype and how they correctly connect 
themselves forming the functional network in the developing brain is still an open question. 
Indeed the specific factors that precisely orchestrate molecular events are not yet completely 
identified. Likewise, midbrain development has a lot of unknown features since it is involved in 
many aspects of brain function and therefore many molecules influence its development. 
The development of DA neurons is articulated in a continuous multi-step process in which can 
be recognized mainly four phases: induction, specification, differentiation and maturation. For 
every step a great number of molecules is involved, and some of them have different roles in 
different phases, mostly depending from their concentration. 
Among these molecules, the transcription factors Nurr1 and Pitx3 are considered master genes 
of DA neuron development and differentiation, as shown by specific alteration in mesDA nuclei 
observed in knock-out mice (Zetterstrom et al. 1997, Rieger at al. 2001). The hierarchy between 
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those two factors has been unveiled only in 2012, when experiment performed in my host lab 
(Volpicelli et al. 2012) described the direct regulation of Pitx3 by Nurr1. 
My PhD work has been aimed to recapitulate in vitro the development of mesencephalic 
dopaminergic neurons (mesDA) and to dissect the molecular events that orchestrate this process. 
To this purpose I firstly set up an in vitro mesDA differentiation protocol by over-expressing the 
transcription factors Nurr1 and Lmx1a, and validated the flexibility and reproducibility of this 
protocol into different cell types. Thus, I used the mesDA-like cells 1) to study the relationship 
between the two factors Nurr1 and Lmx1a, and 2) to identify new partners and target genes 
regulated by these transcription factors.  
As a starting point, midbrain neuronal progenitor cells (NPCs) were isolated and cultured to 
promote neuronal differentiation and survival of TH+ cells with SHH and FGF8, as described 
previously  (Volpicelli et al. 2004). The over-expression of Nurr1 enhances TH expression, and 
the combination with Lmx1a potentiates the pro-dopaminergic enrichment not only in NPC but 
also in different cellular models I used such as A1, reprogrammed ADAS and MEF. This effect 
was absent in epiSCS, most probably due to the low infection rate achieved in this cell model. 
Which are the molecular bases of this interaction is still an open issue. In agreement with known 
data there are different possibilities: Lmx1a may act as a precursor factor that promotes mesDA 
phenotype by inhibition of alternative fates in developing midbrain (Andersson et al. 2006); or 
being part of a autoregulatory loop directly regulating Nurr1 and Pitx3 (Chung et al. 2009). 
Probably, both hypotheses are true. In epiSC, the over-expression of Lmx1a is able to increase 
TH mRNA most probably through the activation of the Wnt’s pathway and in NPCs Lmx1a 
promotes TH expression only in combination with Nurr1. 
Thus I hypothesized that Lmx1a cooperates with Nurr1 to enhance TH regulation by several 
possible mechanisms of action:: 
− Lmx1a binds Nurr1 and modulates its activity directly or indirectly by a 
third factor; 
− Lmx1a influences the binding of Nurr1 on TH promoter by epigenetic 
modifications of the DNA binding motif itself.  
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Since I observed TH+ cells that do not express both transcription factors (TH+/Nurr1+/Lmx1a- 
or TH+/Nurr1-/Lmx1a+), I couldn’t exclude that this cooperation occurs by intercellular pro-
differentiating molecules released by Lmx1a+ on Nurr1+ cells, or vice versa. 
Thus, to dissect the mechanisms of the cooperation between these two TFs, I proceeded in 
different directions. 
Firstly, since Nurr1 is an orphan nuclear receptor, I considered that its activation could be 
modulated by the binding of one or different co-factors to the LBD (Perlmann et al. 2004). To 
investigate the possibility that Lmx1a could bind the LBD, thus potentiating the activity of 
Nurr1, I generated lentiviral vectors deleted for the LBD (ΔCter-Nurr1); as control I over-
expressed Nurr1 lacking the N-terminal transactivation domain (ΔCter-Nurr1) or mutated in 
DBD. As expected these last two forms are transcriptionally inactive, while over-expression of 
ΔCter-Nurr1 in mE12.5-PCs increased TH mRNA levels showing the same trend of the full 
length Nurr1 also cooperating with Lmx1a. These results indicate that the synergy between 
Nurr1 and Lmx1a does not require LBD and that this domain is not necessary to Nurr1 activity. 
Thus, my data corroborate the idea that the activity of Nurr1 is ligand-independent, but can be 
modulated by other factors like Lmx1a. To verify this idea additional experiments, such as Co-
immunoprecipitation of the two proteins, will be done. 
To analyze if Lmx1a binds TH promoter and changes its responsiveness to Nurr1, ChIP 
experiment was performed on mE12.5-PCs, however the mesDA population is too much 
heterogeneous to give precise data. To perform reliable ChIP assays these experiments will be 
made in ESCs expressing permanently Nurr1, Lmx1a or both.  Furthermore, the ESCs expressing 
both Nurr1 and Lmx1a could be compared to co-cultured cells expressing Lmx1a+ and Nurr1+ 
alone to verify whether the cooperation observed is intracellular or intercellular.  
The data here presented support the capability of Nurr1 and Lmx1a over-expression to induce 
mesDA phenotype. In particular mE12.5-PCs and A1 cells showed an increase of mature markers 
of mesDA neurons such as VMAT2 and DAT, and of survival markers Pitx3 and GDNF 
receptor c-Ret, while markers of cathecolaminergic neurons (DBH and PNMT), of other 
neuronal subtype (SERT, TPH2 and GAD65) or of glial (GFAP, Nestin and Sox2) population 
were reduced or absent.  
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From a functional point of view it is important to mention the ability of Nurr1 to induce cell 
cycle arrest. Indeed the over-expression of Nurr1 in A1 cells promotes cell cycle arrest and put the 
cells in quiescence (G0), preventing the serum-induced reactivation of mitosis. This activity of 
Nurr1 is essential to allow maturation of mesDA neurons in vitro and most probably depends on 
cyclins regulation, as previously proposed for p57Kip2 (Joseph et al. 2003). Interestingly, also the 
over-expression of Pitx3 induces cell cycle exit similar to that induced by Nurr1. Since Nurr1 
directly regulates Pitx3 (Volpicelli et al. 2012), we could argue that Nurr1 activates Pitx3 thus 
mediating cyclin regulation. We may hypothesize that neurons exit from cell cycle to form stable 
synapses and complete maturation as last phases of their development (Frade et al. 2015). 
My results confirm that it is possible to reproduce in vitro mesDA phenotype from different 
cell types in order to generate model systems useful to better understand the process involved in 
development and neurodegeneration of mesDA neurons. Indeed, the in vitro model generated 
can be suitable to identify the synergic relationship between Nurr1 and Lmx1a. 
Starting from the data obtained during dopaminergic differentiation of epics, it was possible to 
demonstrate that miR-218-1 and miR-204 play a role in mesDA development. Indeed the over-
expression of miR-218-1, in combination with Nurr1, enhances the number of TH+ cells derived 
from mE12.5-PCs and MEFs while the over-expression of Lmx1a up-regulates miR-204. 
Recently it has been described that both miR-218 and miR-204 are involved in important cellular 
processes associated to motor-neuron development (Amin et al. 2015, Thiebes et al. 2015) and 
retinal disease (Conte et al. 2014), respectively. Nevertheless the molecular and cellular events 
controlled by these microRNAs are largely unknown. Thus, since these miRNAs are expressed in 
dopaminergic neurons, we could expect a role also in mesDA neurons development.  
In future our goals will be to identify the Lmx1a activated pathways and to characterize the role 
of Lmx1a in Nurr1 activity modulation.  
These information, combined with the capability to generate mesDA neurons from non-
neuronal cells, can lead to the obtainment of a more powerful in vitro model system for the study 
of PD or other diseases affecting the dopaminergic system. Moreover, the ability to generate 
patient-specific mesDA from adult differentiated cells could pave the way for cell replacement 
therapies. 
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6 -  LIST OF ABBREVIATIONS 
	  
A 
A1   mes-c-myc-A1 cell line 
A   Lentiviral particles carryng Ascl1 cDNA  
A(n)   Catecholaminergic nuclei 
AADC                 Aromatic L-amino acid decarboxylase 
ADHD               Attention deficit hyperactivity disorder 
ADAS   Adipose derived adult stem cells 
AF1   Transactivation domain of Nurr1 
Ahd2                    Aldehydedehydrogenase2 
AK                       Aphakia mice 
AN   Lentiviral particles carryng Ascl1 and Nurr1 cDNAs 
ANL   Lentiviral particles carryng Ascl1, Nurr1 and Lmx1a cDNAs 
Ascl1   Achaete-scute homolog 1 
 
 
B 
BDNF   Brain deriven neurotrophic factor 
bFGF   Basic fibroblast growth factor (FGF2) 
 
C 
cAMP   Cyclic Adenosine Mono-phosphate 
CDNF   Cerebral dopamine neurotrophic factor 
ChIP   Chromatin immunoprecipitation 
CNS   Central nervoussystem 
CoIP   Co-immunoprecipitation 
COMT   Catechol-O-methyltransferase 
c-Ret   GDNF receptor 
 
    
 
D 
∆Cter-Nurr1  Nurr1 deleted of C-terminus portion  
∆Nter-Nurr1  Nurr1 deleted of N-terminus portion 
DA    Dopamine / Dopaminergic 
DBD   DNA binding domain 
DBH   Dopamine ß-hydroxylase 
DRD   DA receptor 
DAT                    Dopamine active transporter (Slc6a3) 
DIV   Days in vitro 
Dmrt5            Doublesex and mab-3related transcription factor 5 
DOPAC               3,4-dihydroxyphenylacetic acid 
Dox   doxycyxline 
Dsh                       Dishevelled 
 
E 
E   Embryonic day  
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En1/2   Engrailed 1 and 2 
epiSC   Epiblast stem cells 
Eph   Ephrines 
ESC   Embryonic stem cells 
 
F 
FBS   Foetal bovine serum 
FCS   Foetal calf serum 
FGF8   Fibroblast growth factor 8 
FP                      Floor plate 
FoxA1/2  Forkhead box protein A1/A2 
Fz    Frizzled 
Fz3   Frizzled 3 
Fz6             Frizzled 6 
 
G 
GABA   γ-Aminobutyric acid 
GAD65   Glutamate decarboxylase 2 
GDNF   Glial cell-derived neurotrophic factor 
GFAP   Glial fibrillary acidic protein 
GFP   Green fluorescent protein 
GPe   external Globus pallidus 
GPi   internal Globus pallidus 
 
H 
HEK293T  Human embryonic kidney cell line 293T 
hESC   Human embryonic stem cells 
hiPSC   Human inducedpluripotentstemcells 
HPRT   Hypoxanthine Phosphoribosyltransferase 
HVA   Homovanillic acid 
 
I  
IAC   Istituto per le Applicazioni del Calcolo 
iDA   Induceddopaminergic cells 
iN   Induced neuronal cells 
IF   Immunofluorescence analysis 
IGB-ABT  Institute of genetics and biophysics Adriano Buzzati Traverso 
iPSC   Induced pluripotent stem cells 
IsO   Isthmic organizer 
 
K 
KO   Knock-out 
 
L 
LBD   Ligand binding domain 
L-DOPA  L–3,4–dihydroxyphenylalanine (levodopa) 
LIF   Leukemia inhibitory factor 
Lmx1a   LIM-homeodomain factor1a 
Lmx1b   LIM-homeodomain factor1b 
LV   Lentiviral particles 
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MAO   Monoamine oxidase 
mDA   Midbrain dopaminergic neurons 
MHB                    Mid-hindbrain boundary 
Mb   Midbrain 
MCLp   Mesocorticolimbic pathway 
mE12.5-PCs  Mouse embryonic primary cultures from E12.5 midbrains 
MEF   Mouse embryonic fibroblasts 
miRNA   microRNA 
mRNA   messanger RNA 
Msx1   Msh homeobox 1 
 
N 
NBRE   NGF rensponsive elements 
NC   Notocord 
NEAA   Non-essential aminoacids 
NES   Nuclear exporting sequences 
Ngn2   Neurogenin 2 
Nkx2.2   NK2 Homeobox 2 
Nkx6.1   NK6 Homeobox 1 
NLS   Nuclear localization sequences 
Nr4a1   Alias for Nurr77 
Nr4a2   Alias for Nurr1 
Nr4a3   Alias for Nor-1 
NSC   Neuralstemcells 
NSp   Nigrostriatalpathway 
Nurr1         Nuclear Receptor Related 1 protein 
Nurr1C280A/E281/A  Nurr1 mutated in two aminoacidic residues 
 
 
O 
OB   Olfactory bulbs 
Otx2   Orthodenticle Homeobox 2 
OV                Otic vescicle 
 
P 
p57Kip2   Cyclin-dependent kinase inhibitor 1C 
PABP        poly(A)-binding protein 
PD   Parkinson’s disease 
Pen/Strep  Streptomycin and Penicillin 
PhD   Doctor of Philosophy 
Pitx3   Pituitary homeobox 3 
PNMT   Phenylethanolamine N-methyltransferase 
pre-miRNA  Precursor-miRNA 
pri-miRNA  Primary-miRNA 
PSF   Splicing factor PTB-associated 
PTB              Polypirimidine–tract-binding-protein 
Ptc1                     Patched 1 
PKA                 Protein Kinase A 
 
R 
RA   Retinoic acid 
RP   Roof plate 
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RRF   Retrorubral field 
RT-PCR  real time PCR 
RXR                    Retinoic acid receptor 
 
S 
SAG   Smoothened Agonist 
SC   Spinal cord 
SEM   Standard error of the mean 
SERT   serotonin transporter 
SHH                     Sonic Hedgehog 
Slit2   Slit Guidance Ligand 2 
Smo   Smoothened 
SN   Substantia Nigra 
SNc   Substantia Nigra pars compacta 
SNr   Substantia Nigra pars reticulata 
Sox2   SRY (sex determining region Y)-box 2 
STN                  Subthalamic nucleus 
 
T 
TF   Transcription factors 
TGFβ   Transforming growth factor β 
TH   Tyrosine Hydroxylase 
TIGEM  Telethon Institute of Genetics and Medicine 
TPH2   Tryptophan hydroxylase 2 
 
U 
UTR   Untranslated regions 
 
V 
Vmat2     Vesicular monoamine transporter 
VTA             Ventral Tegmental Area 
 
W 
Wnt   Wingless-Type MMTV Integration Site Family 
wt   Wilde type 
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